<!DOCTYPE html><html lang="en-GB"><head><meta charSet="utf-8"/><meta http-equiv="x-ua-compatible" content="ie=edge"/><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/><style data-href="/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css" id="gatsby-global-css">.page-header{margin:0 0 3rem}.page-header__pre-heading{font-size:1.125rem;line-height:1.5rem;display:block;margin:0}.page-header__heading{font-size:2.75rem;line-height:3.5rem;margin:0 0 .5rem}.page-header__lead{font-size:1.25rem;line-height:1.75rem;margin:0 0 .5rem}.page-header__cta{font-size:1rem;line-height:1.5rem;display:block;margin:0}@media print{.page-header__cta{display:none!important}}.breadcrumbs{font-size:1rem;line-height:1.5rem;list-style:none;margin:.5em 0 2em;max-width:100%;padding:0}@media print{.breadcrumbs{display:none!important}}.breadcrumbs__crumb{display:inline-block}.breadcrumbs__crumb:before{content:">";font-size:80%;margin:0 .25em}.breadcrumbs__crumb:first-child:before{display:none}.breadcrumbs a{color:#222;text-decoration:underline}.breadcrumbs a:hover{text-decoration:none}.breadcrumbs a:focus{color:#005ea5}.breadcrumbs a:active{color:#222}.OldIEMessage-module--container--2Z9pT{max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);margin:auto auto 1rem}.OldIEMessage-module--alert--3CB3M{background:#ffdfa4;border:1px solid #966f2f;margin:1rem auto 0;max-width:73.125rem;padding:1rem}.OldIEMessage-module--alert--3CB3M a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.OldIEMessage-module--alert--3CB3M a:visited{color:#4c2c92}.OldIEMessage-module--alert--3CB3M a:hover{color:#2e8aca}.OldIEMessage-module--alert--3CB3M a:focus{outline:.25rem solid #0092a6;color:#005ea5}.OldIEMessage-module--alert--3CB3M a:active{color:#222}.OldIEMessage-module--alert--3CB3M h2{margin-top:0}.OldIEMessage-module--alert--3CB3M h2,.OldIEMessage-module--alert--3CB3M p{max-width:600px}.OldIEMessage-module--lastP---CQws{margin-bottom:0}.CoronaMessage-module--wrapper--zRiaV{background:#ffeb3b;padding:.5rem 0}.CoronaMessage-module--wrapper--zRiaV p{margin-top:0}.CoronaMessage-module--wrapper--zRiaV a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.CoronaMessage-module--wrapper--zRiaV a:visited{color:#4c2c92}.CoronaMessage-module--wrapper--zRiaV a:hover{color:#2e8aca}.CoronaMessage-module--wrapper--zRiaV a:focus{outline:.25rem solid #0092a6;color:#005ea5}.CoronaMessage-module--wrapper--zRiaV a:active{color:#222}@media print{.CoronaMessage-module--wrapper--zRiaV{display:none}}.CoronaMessage-module--container--36Biz{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.CoronaMessage-module--container--36Biz>:last-child{margin-bottom:0}.SubNav-module--wrapper--yAXWY{background:#fff;color:#000;display:block}.SubNav-module--list--1K9bK{margin:0;padding:0}.SubNav-module--list--1K9bK li{list-style:none;margin:0}.SubNav-module--link--39i23{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222;display:block;font-weight:400;padding:.5rem 1rem .5rem 2rem;text-decoration:none}.SubNav-module--link--39i23:focus{color:#222;outline:.25rem solid #0092a6;outline-offset:-.5rem}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222}.SubNav-module--link--39i23:hover{background:#d6d6d6;color:#222;text-decoration:underline}.SubNav-module--imageLink--3xwIS{display:none}@media(min-width:56.25em){.SubNav-module--wrapper--yAXWY{border-bottom:.125rem solid #004650;bottom:0;height:3rem;left:0;position:absolute;width:100%}.SubNav-module--imageLink--3xwIS{display:inline-block}.SubNav-module--list--1K9bK{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);height:100%}.SubNav-module--list--1K9bK li{display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23{border:0;display:block;height:100%;padding:0 1rem}.SubNav-module--link--39i23[aria-current=page],.SubNav-module--link--39i23[aria-current=true]{background:transparent}.SubNav-module--link--39i23[aria-current=page]:after,.SubNav-module--link--39i23[aria-current=true]:after{display:none}.SubNav-module--link--39i23:before{content:"";display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border:0}}.SubNav-module--image--uq-a2{height:100%}.Nav-module--link--3JzDA .Nav-module--tooltip--1Uj-W{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Nav-module--link--3JzDA:focus-visible .Nav-module--tooltip--1Uj-W{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Nav-module--visuallyHidden--ORHqX{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Nav-module--wrapper--2_xng{display:none;position:relative}@media print{.Nav-module--wrapper--2_xng{display:none!important}}@media(min-width:56.25em){.Nav-module--wrapper--2_xng{display:block}}.Nav-module--wrapperExpanded--3RxQB{display:block}.Nav-module--nav--2aQpa abbr[title]{border-bottom:0;cursor:help;text-decoration:none}.Nav-module--myAccount--3lsif{border-top:1px solid #fff}@media(min-width:56.25em){.Nav-module--myAccount--3lsif{display:none}}.Nav-module--myAccountHeading--1A5_B{border:.25rem solid #004650;font-size:100%;margin:0;padding:.5rem 1rem}.Nav-module--menuWrapper--2fp8S{background:#004650;color:#fff;padding:.25rem 0}.Nav-module--menuList--264L-{list-style:none;margin:auto;padding:0}.Nav-module--menuList--264L->li{margin:0}a.Nav-module--link--3JzDA{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#fff;display:block;font-weight:400;padding:.5rem 1rem;text-decoration:none}a.Nav-module--link--3JzDA span{text-decoration:inherit}a.Nav-module--link--3JzDA:focus{color:#fff;outline:.25rem solid #fff;outline-offset:-.5rem;z-index:1}a.Nav-module--link--3JzDA:visited{color:#fff}a.Nav-module--link--3JzDA:active{background:#acadad;color:#222}a.Nav-module--link--3JzDA:hover{background:#d6d6d6;color:#222;text-decoration:underline}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{background:#fff;color:#222;font-weight:700}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-color:#0092a6;outline-offset:-.25rem}@media(min-width:56.25em){.Nav-module--wrapperWithSubLinks--3PUfX{padding-bottom:3rem}.Nav-module--menuList--264L-{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);display:-webkit-flex;display:flex;-webkit-flex-direction:row;flex-direction:row;-webkit-flex-wrap:nowrap;flex-wrap:nowrap;-webkit-justify-content:space-between;justify-content:space-between}.Nav-module--menuList--264L->li{-webkit-flex-grow:1;flex-grow:1}a.Nav-module--link--3JzDA{border-left-width:0;border-right-width:0;display:-webkit-flex;display:flex;-webkit-flex-direction:column;flex-direction:column;height:100%;-webkit-justify-content:center;justify-content:center;line-height:1.25;margin:0;padding:.5rem;position:relative;text-align:center}a.Nav-module--link--3JzDA:focus{outline-offset:-.25rem}a.Nav-module--link--3JzDA span{display:inline-block;vertical-align:middle;white-space:normal}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{margin:0 .25rem}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-offset:-.5rem}a.Nav-module--link--3JzDA[aria-current=page]:after,a.Nav-module--link--3JzDA[aria-current=true]:after{background:#fff;content:"";display:block;height:.25rem;left:0;position:absolute;top:100%;width:100%}a.Nav-module--link--3JzDA[aria-current=page]:hover:after,a.Nav-module--link--3JzDA[aria-current=true]:hover:after{background:#d6d6d6}}@media(min-width:56.25em)and (min-width:75em){a.Nav-module--link--3JzDA{padding:1rem}}.Autocomplete-module--ac--2PqiF .autocomplete__wrapper{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input{-webkit-appearance:none;border:1px solid #222;border-radius:0;box-sizing:border-box;margin-bottom:0;width:100%}.Autocomplete-module--ac--2PqiF .autocomplete__input{background-color:#e9e9e9!important;height:2.5rem!important;margin:0!important;max-width:100%!important;position:relative;z-index:101}.Autocomplete-module--ac--2PqiF .autocomplete__input:focus{outline:3px solid #0092a6;outline-offset:-3px;z-index:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-webkit-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-moz-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input:-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__hint{color:#bfc1c3;position:absolute}.Autocomplete-module--ac--2PqiF .autocomplete__input--default{padding:.5rem}.Autocomplete-module--ac--2PqiF .autocomplete__input--focused{outline:3px solid #0092a6;outline-offset:-3px}.Autocomplete-module--ac--2PqiF .autocomplete__input--show-all-values{padding:4px 34px 4px 4px;cursor:pointer}.Autocomplete-module--ac--2PqiF .autocomplete__dropdown-arrow-down{z-index:-1;display:inline-block;position:absolute;right:8px;width:24px;height:24px;top:10px}.Autocomplete-module--ac--2PqiF .autocomplete__menu{background-color:#fff;border:1px solid #d6d6d6;border-top:0;color:#34384b;margin:0;max-width:100%;padding:0;text-align:left;width:-webkit-calc(100vw - 2rem);width:calc(100vw - 2rem)}@media(min-width:37.5em){.Autocomplete-module--ac--2PqiF .autocomplete__menu{width:100%}}.Autocomplete-module--ac--2PqiF .autocomplete__menu--visible{display:block}.Autocomplete-module--ac--2PqiF .autocomplete__menu--hidden{display:none}.Autocomplete-module--ac--2PqiF .autocomplete__menu--overlay{box-shadow:0 .25rem 1rem .25rem rgba(0,0,0,.1);left:0;position:absolute;top:100%;z-index:100}.Autocomplete-module--ac--2PqiF .autocomplete__menu--inline{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option{border-left-width:0;border-bottom:1px solid #d6d6d6;border-right-width:0;border-top-width:1px;color:#005ea5;cursor:pointer;display:block;margin:0;position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option a{color:inherit;display:block;font-weight:400;padding:.5rem;text-decoration:none}.Autocomplete-module--ac--2PqiF .autocomplete__option mark{background:0;color:inherit;font-weight:700;padding:0}.Autocomplete-module--ac--2PqiF .autocomplete__option>*{pointer-events:none}.Autocomplete-module--ac--2PqiF .autocomplete__option:first-of-type{border-top-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option:last-of-type{border-bottom-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option--odd{background-color:#fafafa}.Autocomplete-module--ac--2PqiF .autocomplete__option--focused,.Autocomplete-module--ac--2PqiF .autocomplete__option:hover{background-color:#e9e9e9;color:#005ea5;outline:none;text-decoration:underline}.Autocomplete-module--ac--2PqiF .autocomplete__option--no-results{background-color:#fafafa;color:#646b6f;cursor:not-allowed}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input,.Autocomplete-module--ac--2PqiF .autocomplete__option{font-size:16px;line-height:1.25}.Search-module--search--2wNll{margin:0;padding-right:2.5rem;position:relative}.Search-module--label--1rrog{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute!important;width:1px}.Search-module--button--2FbnI{background:#393939;border:0;color:#fff;cursor:pointer;height:2.5rem;min-width:2.5rem;padding:0 .5rem;position:absolute;right:0;text-align:center;top:0;z-index:101}.Search-module--button--2FbnI:focus{outline:.25rem solid #0092a6}.Search-module--button--2FbnI .Search-module--icon--2JB42{font-size:150%;vertical-align:middle}.Account-module--account--1BtRh{position:relative}.Account-module--button--zZii1{background:#fff;border:1px solid #222;color:#222;cursor:pointer;display:inline-block;font-family:inherit;font-size:inherit;font-weight:400;height:2.5rem;line-height:2.5rem;padding:0 .5rem;text-decoration:none;vertical-align:middle;white-space:nowrap}.Account-module--button--zZii1:focus{outline:.25rem solid #0092a6}.Account-module--button--zZii1:visited{color:#222}.Account-module--button--zZii1:hover{border:1px solid #222}.Account-module--myAccount--3jTaq:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Account-module--myAccount--3jTaq[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Account-module--menu--3C46i{background:#fff;border:1px solid #393939;list-style:none;margin:.625rem 0 0;padding:0;position:absolute;right:0;top:100%;z-index:2}.Account-module--menu--3C46i:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i[aria-hidden=true]{display:none}.Account-module--menu--3C46i:before{border-bottom:.5rem solid #393939;border-left:.25rem solid transparent;border-right:.25rem solid transparent}.Account-module--menu--3C46i:after,.Account-module--menu--3C46i:before{bottom:100%;content:"";display:block;height:0;position:absolute;right:1rem;width:0}.Account-module--menu--3C46i:after{border-bottom:.4rem solid #fff;border-left:.2rem solid transparent;border-right:.2rem solid transparent;margin-right:1px}.Account-module--menu--3C46i li{border-top:1px solid #d6d6d6;list-style:none;margin:0}.Account-module--menu--3C46i a{color:#005ea5;display:block;padding:.5rem 1rem;text-decoration:none;white-space:nowrap}.Account-module--menu--3C46i a:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i a:hover{background:#e9e9e9;text-decoration:underline}.Header-module--header--3os44{background:#fff;border-bottom:.125rem solid #004650;box-sizing:border-box;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif}.Header-module--header--3os44 *,.Header-module--header--3os44 :after,.Header-module--header--3os44 :before{box-sizing:inherit;font-family:inherit}@media print{.Header-module--header--3os44{border-bottom:none}}.Header-module--container--1mfIr{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0 0}.Header-module--container--1mfIr:after{clear:both;content:"";display:table}.Header-module--home--1TCPb{color:#000;display:inline-block;float:left;height:1.875rem;margin-bottom:1rem}@media print{.Header-module--home--1TCPb:after{content:none!important}}.Header-module--home--1TCPb:focus{outline:.25rem solid #0092a6}.Header-module--home--1TCPb:visited{color:#000}.Header-module--home--1TCPb .Header-module--icon--4LSt5{height:100%;width:auto}.Header-module--wrapper--2e13D{display:-webkit-flex;display:flex;-webkit-flex-grow:1;flex-grow:1;float:right;-webkit-justify-content:space-between;justify-content:space-between;margin-bottom:1rem;width:50%}@media print{.Header-module--wrapper--2e13D{display:none!important}}.Header-module--wrapper--2e13D:after{clear:both;content:"";display:table}.Header-module--search--2nfnz{-webkit-flex-grow:1;flex-grow:1;float:left;margin-right:1rem;min-width:66.6666666667%}.Header-module--mobileMenuBtn--1LgyL{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:1px solid #222;float:right;font-family:inherit;font-size:110%;height:2.5rem;min-width:4.6875rem;white-space:nowrap}.Header-module--mobileMenuBtn--1LgyL:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Header-module--mobileMenuBtn--1LgyL[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Header-module--account--y72Q4{display:none}@media(max-width:56.24em){.Header-module--home--1TCPb{float:none}.Header-module--wrapper--2e13D{float:none;width:auto}}@media(min-width:56.25em){.Header-module--header--3os44{border-bottom:.25rem solid #fff}.Header-module--container--1mfIr{display:-webkit-flex;display:flex;-webkit-justify-content:space-between;justify-content:space-between}.Header-module--home--1TCPb{height:2.5rem;margin-right:2rem}.Header-module--wrapper--2e13D{-webkit-justify-content:flex-end;justify-content:flex-end}.Header-module--search--2nfnz{margin-right:2rem}.Header-module--mobileMenuBtn--1LgyL{display:none}.Header-module--account--y72Q4{display:block}}.SkipLinks-module--list--1WwLa{list-style:none;margin:0;padding:0}@media print{.SkipLinks-module--list--1WwLa{display:none!important}}.SkipLinks-module--list--1WwLa li{list-style:none;margin:0}.SkipLinks-module--link--hkZw8{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.SkipLinks-module--link--hkZw8:focus{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;left:.25rem;outline:3px solid #0092a6;overflow:visible;padding:.5rem 1rem;position:absolute;top:.25rem;white-space:nowrap;width:auto;z-index:1}.Social-module--wrapper--2nKsd{clear:left}.Social-module--list--E5R5J{list-style:none;margin:0;max-width:100%;padding:0}.Social-module--list--E5R5J li{margin:0 0 .25rem}.Social-module--list--E5R5J svg{margin:-.125rem .25rem 0 0;vertical-align:middle}@media(min-width:37.5em){.Social-module--list--E5R5J li{float:left;margin:0 1rem 0 0}}@media(min-width:56.25em){.Social-module--wrapper--2nKsd{clear:none}.Social-module--wrapper--2nKsd li{float:none;margin:0 0 .25rem}}.Legal-module--wrapper--3AYMO{font-size:.875rem;line-height:1.25rem;background:#393939;padding:1rem 0}.Legal-module--wrapper--3AYMO a{text-decoration:underline}.Legal-module--container--3TTBh{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.Legal-module--menu--1e1Iy{margin:0 0 1rem}@media print{.Legal-module--menu--1e1Iy{display:none!important}}.Legal-module--menu--1e1Iy ul{list-style:none;margin:0;max-width:100%;padding:0}.Legal-module--menu--1e1Iy li{margin:0}.Legal-module--menu--1e1Iy a{display:block}.Legal-module--copyright--34nsI{font-size:.875rem;line-height:1.25rem;margin:0}@media print{.Legal-module--copyright--34nsI{float:none!important;max-width:100%}}@media(min-width:37.5em){.Legal-module--menu--1e1Iy li{display:inline-block;margin-right:1rem}}@media(min-width:75em){.Legal-module--wrapper--3AYMO:after,.Legal-module--wrapper--3AYMO:before{content:" ";display:table}.Legal-module--wrapper--3AYMO:after{clear:both}.Legal-module--menu--1e1Iy{float:left;margin:0}.Legal-module--copyright--34nsI{float:right}}.Services-module--link--2y_1q .Services-module--tooltip--pg3nW{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Services-module--link--2y_1q:focus-visible .Services-module--tooltip--pg3nW{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Services-module--visuallyHidden--t9mfm{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Services-module--wrapper--2qOoE{margin:0 0 2rem}.Services-module--list--3SZQu{list-style:none;margin:0;padding:0}.Services-module--list--3SZQu li{margin:0 0 .25rem}@media(min-width:37.5em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;width:33.3333333333%}}@media(min-width:56.25em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;margin:0;width:25%}}.Pages-module--wrapper--30REl{margin:0 0 2rem}.Pages-module--list--vvSk4{list-style:none;margin:0;padding:0}.Pages-module--list--vvSk4 li{margin:0 0 .25rem}@media(min-width:25em){.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}@media(min-width:37.5em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 0 0 2rem;width:66.6666666667%}}@media(min-width:56.25em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 2rem;width:50%}.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}.Footer-module--link--CGIYk .Footer-module--tooltip--1zoJv{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Footer-module--link--CGIYk:focus-visible .Footer-module--tooltip--1zoJv{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Footer-module--visuallyHidden--3CCnP{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Footer-module--footer--2QrGZ{background:#222;box-sizing:border-box;color:#fff;contain-intrinsic-size:350px;content-visibility:auto;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;margin:2rem 0 0}.Footer-module--footer--2QrGZ a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.Footer-module--footer--2QrGZ a:visited{color:#fff}.Footer-module--footer--2QrGZ a:hover{color:#d6d6d6}.Footer-module--footer--2QrGZ a:focus{outline:.25rem solid #fff;color:#fff}.Footer-module--footer--2QrGZ a:active{color:#d6d6d6}.Footer-module--footer--2QrGZ *,.Footer-module--footer--2QrGZ :after,.Footer-module--footer--2QrGZ :before{box-sizing:inherit}.Footer-module--footer--2QrGZ a{font-weight:400}.Footer-module--container--1iuoB{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0}.Footer-module--container--1iuoB:after,.Footer-module--container--1iuoB:before{content:" ";display:table}.Footer-module--container--1iuoB:after{clear:both}@media print{.Footer-module--container--1iuoB{display:none!important}}.Footer-module--logo--3DGKv{display:block;height:0;margin:0 0 2rem;padding:0 0 29.0496453901px;position:relative;width:80px}.Footer-module--logo--3DGKv svg{display:block;height:100%!important;left:0;position:absolute;top:0;width:100%!important}@media(min-width:56.25em){.Footer-module--logo--3DGKv{margin-bottom:1rem}}.BackToTop-module--wrapper--2Z0EU{margin-top:3rem}@media print{.BackToTop-module--wrapper--2Z0EU{display:none}}.BackToTop-module--nav--1DPZ6{background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}.BackToTop-module--anchor--1Nia6{display:block;line-height:1rem;padding:1rem 0}.BackToTop-module--anchor--1Nia6:visited{color:#005ea5}.BackToTop-module--anchor--1Nia6 svg{-webkit-transition:all .25s ease;transition:all .25s ease}.BackToTop-module--anchor--1Nia6:hover{background:#f4f4f4}.BackToTop-module--anchor--1Nia6:hover svg{-webkit-transform:translateY(-.125rem);transform:translateY(-.125rem)}@supports((position:-webkit-sticky) or (position:sticky)){.BackToTop-module--wrapper--2Z0EU{bottom:0;left:0;margin:0;pointer-events:none;position:absolute;right:0;top:min(100vh,-webkit-calc(100% - 3rem));top:min(100vh,calc(100% - 3rem));width:100%;z-index:99}.BackToTop-module--nav--1DPZ6{position:-webkit-sticky;position:sticky;pointer-events:all;top:-webkit-calc(100vh - 3rem);top:calc(100vh - 3rem);background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-regular.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-regular.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:italic;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-italic.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-italic.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:700;src:local("Lato"),url(../../../../fonts/lato-v17-latin-700.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-700.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:900;src:local("Lato"),url(../../../../fonts/lato-v17-latin-900.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-900.woff) format("woff")}/*! normalize.css v8.0.1 | MIT License | github.com/necolas/normalize.css */html{line-height:1.15;-webkit-text-size-adjust:100%}body{margin:0}main{display:block}h1{font-size:2em;margin:.67em 0}hr{box-sizing:content-box;height:0;overflow:visible}pre{font-family:monospace,monospace;font-size:1em}a{background-color:transparent}abbr[title]{border-bottom:none;text-decoration:underline;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b,strong{font-weight:bolder}code,kbd,samp{font-family:monospace,monospace;font-size:1em}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sub{bottom:-.25em}sup{top:-.5em}img{border-style:none}button,input,optgroup,select,textarea{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=button],[type=reset],[type=submit],button{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}fieldset{padding:.35em .75em .625em}legend{box-sizing:border-box;color:inherit;display:table;max-width:100%;padding:0;white-space:normal}progress{vertical-align:baseline}textarea{overflow:auto}[type=checkbox],[type=radio]{box-sizing:border-box;padding:0}[type=number]::-webkit-inner-spin-button,[type=number]::-webkit-outer-spin-button{height:auto}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}[type=search]::-webkit-search-decoration{-webkit-appearance:none}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}details{display:block}summary{display:list-item}[hidden],template{display:none}.show-print{display:none!important}@media print{.show-print{display:block!important}}@media print{.hide-print{display:none!important}}@media print{.remove-appended-print-link:after{content:none!important}}@media print{*{background:transparent!important;box-shadow:none!important;color:#000!important;text-shadow:none!important}a,a:visited{text-decoration:underline}}@media print{h1 a:after,h2 a:after,h3 a:after,h4 a:after,h5 a:after,h6 a:after{content:none!important}}@media print{a[href]:after{content:" (" attr(href) ")"}}@media print{abbr[title]:after{content:" (" attr(title) ")"}}@media print{.ir a:after,a[href^="#"]:after,a[href^="javascript:"]:after{content:""}}@media print{blockquote,pre{border:1px solid #999;page-break-inside:avoid}}@media print{thead{display:table-header-group}}@media print{img,tr{page-break-inside:avoid}}@media print{img{max-width:100%!important}}@media print{img:not([alt]),img[alt=""]{display:none!important}}@media print{@page{margin:.5cm}}@media print{h2,h3,p{orphans:3;widows:3}}@media print{h2,h3{page-break-after:avoid}}.clearfix:after,.clearfix:before{content:" ";display:table}.clearfix:after{clear:both}.container{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.container--full{max-width:100%;padding:0 2%;width:auto}html{box-sizing:border-box;font-size:.9375rem;overflow-x:hidden}html *,html :after,html :before{box-sizing:inherit}@media(min-width:56.25em){html{font-size:1.03125rem;font-size:-webkit-calc(.375rem + 1vw);font-size:calc(.375rem + 1vw)}}@media(min-width:75em){html{font-size:1.125rem}}body{background:#f4f4f4;color:#222;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;font-style:normal;line-height:1.5rem;overflow-x:hidden;text-rendering:optimizelegibility}img{max-width:100%}hr{background:0;border:0;border-top:.0625em solid #adadad;margin:2em 0;padding:0}.p,p{font-size:1rem;line-height:1.5rem;font-feature-settings:"kern","onum","liga"}.lead,.p,p{margin-bottom:1rem;margin-top:1rem;font-weight:400;max-width:66ch}.lead{font-size:1.25rem;line-height:1.75rem}code{background:#e9e9e9;border:1px solid #adadad;border-radius:.125em;color:#222;display:inline-block;font-family:Monaco,Menlo,Consolas,Courier New,monospace;margin:0 0 .125em;padding:0 .25em}pre code{background:transparent;border:0;margin:0}.mark,mark{background-color:#fff999;padding:0 .25em}.small,small{font-size:85%}.h6,h6{font-size:1rem}.h5,.h6,h5,h6{line-height:1.5rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h5,h5{font-size:1.125rem}.h4,h4{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h3,h3{font-size:1.75rem;line-height:2rem}.h2,.h3,h2,h3{margin-bottom:1rem;margin-top:2rem;clear:both;font-weight:700;max-width:66ch}.h2,h2{font-size:2.25rem;line-height:2.5rem}.h1,.h2+.h3,.h2+h3,h1,h2+.h3,h2+h3{margin-top:0}.h1,h1{font-size:2.75rem;line-height:3.5rem;margin-bottom:1rem;clear:both;font-weight:900;max-width:66ch}.h1+.h2,.h1+h2,h1+.h2,h1+h2{margin-top:0}a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a:visited{color:#4c2c92}a:hover{color:#2e8aca}a:focus{outline:.25rem solid #0092a6;color:#005ea5}a:active{color:#222}.link--inverse{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.link--inverse:visited{color:#fff}.link--inverse:hover{color:#d6d6d6}.link--inverse:focus{outline:.25rem solid #fff;color:#fff}.link--inverse:active{color:#d6d6d6}.inverse-links a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.inverse-links a:visited{color:#fff}.inverse-links a:hover{color:#d6d6d6}.inverse-links a:focus{outline:.25rem solid #fff;color:#fff}.inverse-links a:active{color:#d6d6d6}.list,ol,ul{font-feature-settings:"kern","onum","liga";margin-left:1rem;max-width:66ch;padding:0}.list--unstyled{list-style:none;margin-left:0;max-width:none;padding:0}.list--loose .list__item,.list--loose li{margin-bottom:.25rem}.list--piped{list-style:none;margin-left:0;padding:0}.list--piped .list__item,.list--piped li{display:inline-block;margin-right:-.25rem}.list--piped .list__item a,.list--piped li a{padding:.5rem}.list--piped .list__item:after,.list--piped li:after{border-left:1px solid #004650;content:"\200B";display:inline-block;margin:0 .5em;overflow:hidden;text-indent:-99px;vertical-align:middle;width:0}.list--piped .list__item:first-child a,.list--piped li:first-child a{padding-left:0}.list--piped .list__item:last-child:after,.list--piped li:last-child:after{display:none}.quote{font-size:1.25rem;line-height:1.75rem;border-left:.25em solid #004650;font-weight:400;margin:2rem 0;padding:0 0 0 4rem;position:relative}.quote:before{color:#004650;content:"\201C";display:block;font-family:Arial,sans-serif;font-size:5rem;font-weight:700;left:0;line-height:.8;position:absolute;text-align:center;top:0;width:4rem}@media print{.quote:before{color:#000}}.quote p{font-size:inherit}.quote cite,.quote footer{font-size:1rem;line-height:1.5rem;font-style:normal}table{background:#fff;border:1px solid #adadad;border-collapse:collapse;display:block;margin:0 0 1rem;max-width:100%;overflow-y:hidden;overflow-x:auto;width:100%!important}table th{vertical-align:bottom}table td{vertical-align:top}table td,table th{border:1px solid #adadad;padding:.5rem;text-align:left}table td:first-child,table th:first-child{border-left:0}table td:last-child,table th:last-child{border-right:0}table td p,table th p{margin-top:0}table :not(thead)+tbody tr:first-child th,table tbody tr:first-child th,table thead tr:first-child th{border-top:0}table tbody tr:last-child td{border-bottom:0}table tbody tr:nth-child(2n)>td{background-color:#e9e9e9}html{overflow-x:visible;scroll-behavior:smooth}@media(prefers-reduced-motion){html{scroll-behavior:auto}}body{font-family:Lato,Trebuchet MS,Roboto,Helvetica Neue,Helvetica,Arial,sans-serif;position:relative}.visually-hidden{position:absolute;overflow:hidden;clip:rect(0 0 0 0);height:1px;width:1px;margin:-1px;padding:0;border:0}#content-start:focus{outline:none}footer{margin-top:0!important}@supports((position:-webkit-sticky) or (position:sticky)){.Layout-module--main--1OIFf{position:relative;padding-bottom:4rem}}.stacked-nav{background:#fff;border:1px solid #adadad;margin:0 0 2em}@media print{.stacked-nav{display:none!important}}.stacked-nav__root{font-size:1rem;line-height:1.5rem;border-bottom:1px solid #adadad;font-weight:700;margin:0;max-width:none;position:relative;text-decoration:none}.stacked-nav__root a{color:#222}.stacked-nav__root--no-link{padding:.5em}.stacked-nav__hint{color:#222;display:block}.stacked-nav__hint :active{color:#fff}.stacked-nav__list{list-style:none;margin:0;max-width:100%;padding:0}.stacked-nav__list-item{border-top:1px solid #adadad}.stacked-nav__content-wrapper{display:block}.stacked-nav a{color:#005ea5;display:block;padding:.5em;position:relative;text-decoration:none}.stacked-nav a[aria-current=page],.stacked-nav a[aria-current=true]{background:#e9e9e9;font-weight:700}.stacked-nav a[aria-current=page]:before,.stacked-nav a[aria-current=true]:before{background:#004650;content:"";display:block;height:100%;left:0;position:absolute;top:0;width:.25em}.stacked-nav a:hover{background:#d6d6d6}.stacked-nav a:active{background:#004650;color:#fff}.stacked-nav a:active span{color:#fff}.stacked-nav__nested{list-style:none;margin:0;padding:0}.stacked-nav__nested .stacked-nav__content-wrapper{padding-left:1rem!important}.stacked-nav__nested ul .stacked-nav__content-wrapper{padding-left:2rem!important}.TopicChaptersMenu-module--toggleButton--2MGXA{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:#e9e9e9;border:1px solid #adadad;color:#005ea5;cursor:pointer;display:block;margin:0 0 2rem;padding:1rem 2rem 1rem .5rem;position:relative;text-align:left;width:100%}.TopicChaptersMenu-module--toggleButton--2MGXA:focus{outline:.25rem solid #0092a6;z-index:1}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=false]+.stacked-nav{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]{border-bottom:0;margin:0}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]+.stacked-nav{display:block}@media(min-width:37.5em){.TopicChaptersMenu-module--toggleButton--2MGXA{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded]+.stacked-nav{display:block}}.TopicChaptersMenu-module--icon--27uSj{color:#005ea5;right:.5rem;position:absolute;top:50%;-webkit-transform:translateY(-50%);transform:translateY(-50%)}.ChapterContents-module--wrapper--3ONbu{position:relative}.ChapterContents-module--printBtn--Rk_Zs{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;bottom:100%;cursor:pointer;display:none;padding:0}.ChapterContents-module--printBtn--Rk_Zs:visited{color:#4c2c92}.ChapterContents-module--printBtn--Rk_Zs:hover{color:#2e8aca}.ChapterContents-module--printBtn--Rk_Zs:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterContents-module--printBtn--Rk_Zs:active{color:#222}.ChapterContents-module--printBtn--Rk_Zs svg{font-size:1.25rem;line-height:1.75rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterContents-module--printBtn--Rk_Zs:hover svg{color:#2e8aca}@media(min-width:37.5em){.ChapterContents-module--wrapper--3ONbu:after,.ChapterContents-module--wrapper--3ONbu:before{content:" ";display:table}.ChapterContents-module--wrapper--3ONbu:after{clear:both}.ChapterContents-module--menu--3Epka{float:left;margin-right:1rem;width:-webkit-calc(25% - .5rem);width:calc(25% - .5rem)}.ChapterContents-module--landing--3klSq,.ChapterContents-module--onThisPage--1333P{float:right;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + .5rem);overflow:hidden;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}}@media(min-width:56.25em){.ChapterContents-module--printBtn--Rk_Zs{display:block;margin-bottom:3rem;position:absolute;right:0}.ChapterContents-module--menu--3Epka{margin-right:2rem;width:-webkit-calc(25% - 1rem);width:calc(25% - 1rem)}.ChapterContents-module--landing--3klSq{width:-webkit-calc(75% - 1rem);width:calc(75% - 1rem)}.ChapterContents-module--onThisPage--1333P{position:-webkit-sticky;position:sticky;top:0;width:-webkit-calc(16.66667% - 1rem);width:calc(16.66667% - 1rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + 1rem);width:-webkit-calc(58.33333% - 2rem);width:calc(58.33333% - 2rem)}}@media print{.ChapterContents-module--menu--3Epka,.ChapterContents-module--onThisPage--1333P,.ChapterContents-module--printBtn--Rk_Zs{display:none}.ChapterContents-module--body--1XBoo{width:100%}}.ChapterBody-module--wrapper--2HCfk>.visually-hidden:first-child+*>:first-child{margin-top:0}.ChapterBody-module--wrapper--2HCfk h2:focus,.ChapterBody-module--wrapper--2HCfk h3:focus,.ChapterBody-module--wrapper--2HCfk h4:focus,.ChapterBody-module--wrapper--2HCfk h5:focus,.ChapterBody-module--wrapper--2HCfk h6:focus{outline:0!important}.ChapterBody-module--basisWrapper--3JBM_{border:1px solid #adadad;margin-top:1rem;max-width:66ch}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-top:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK{padding:0 1rem 1rem}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK>:last-child{margin-bottom:0}.ChapterBody-module--headerWrapper--qSIFw{padding:1rem;position:relative}.ChapterBody-module--toggleBtn--3g0p7{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;cursor:pointer;display:block;margin-top:-.5rem;padding:0}.ChapterBody-module--toggleBtn--3g0p7:visited{color:#4c2c92}.ChapterBody-module--toggleBtn--3g0p7:hover{color:#2e8aca}.ChapterBody-module--toggleBtn--3g0p7:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterBody-module--toggleBtn--3g0p7:active{color:#222}.ChapterBody-module--toggleBtn--3g0p7:after{content:"";height:100%;left:0;position:absolute;top:0;width:100%}.ChapterBody-module--toggleBtn--3g0p7 svg{font-size:1.125rem;line-height:1.5rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterBody-module--toggleBtn--3g0p7:hover svg{color:#2e8aca}.ChapterBody-module--body--2n0CK[aria-hidden=true]{display:none}@media print{.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-bottom:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK[aria-hidden=true]{display:block}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--toggleBtn--3g0p7{display:none}}.ChapterOnThisPage-module--wrapper--2zc7n{margin-bottom:2rem}.ChapterOnThisPage-module--heading--2SdDN{margin-top:0}.ChapterOnThisPage-module--rootList--2II70{list-style:disc}.ChapterOnThisPage-module--subList--Pwxy9{list-style:circle}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:none}@media(min-width:56.25em){.ChapterOnThisPage-module--heading--2SdDN{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:0}@supports((position:-webkit-sticky) or (position:sticky)){.ChapterOnThisPage-module--rootList--2II70 a[aria-current=location]{font-weight:700}.ChapterOnThisPage-module--rootList--2II70 a:focus+.ChapterOnThisPage-module--subList--Pwxy9{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--subList--Pwxy9{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.ChapterOnThisPage-module--subList--Pwxy9:focus-within{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--expandedSubList--1m1WN{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:list-item}}}</style><link rel="sitemap" type="application/xml" href="../../../../sitemap.xml"/><title data-react-helmet="true">Scenario: New or initial management | Management | Depression | CKS | NICE</title><link data-react-helmet="true" rel="search" type="application/opensearchdescription+xml" href="../../../../opensearch.xml" title="CKS"/><link data-react-helmet="true" rel="icon" href="../../../../favicon.ico"/><link data-react-helmet="true" rel="canonical" href="index.html"/><meta data-react-helmet="true" name="description" content="Covers the initial management of a person with depression."/><meta data-react-helmet="true" property="og:description" content="Covers the initial management of a person with depression."/><meta data-react-helmet="true" property="og:url" content="https://cks.nice.org.uk/topics/depression/management/new-or-initial-management/"/><meta data-react-helmet="true" property="og:locale" content="en_GB"/><meta data-react-helmet="true" property="og:type" content="website"/><meta data-react-helmet="true" property="og:title" content="Scenario: New or initial management | Management | Depression | CKS | NICE"/><meta data-react-helmet="true" property="og:image" content="https://cks.nice.org.uk/open-graph-image.png"/><meta data-react-helmet="true" property="og:image:width" content="1200"/><meta data-react-helmet="true" property="og:image:height" content="630"/><meta data-react-helmet="true" name="twitter:card" content="summary"/><meta data-react-helmet="true" name="twitter:image" content="https://cks.nice.org.uk/twitter-summary-image.png"/><meta data-react-helmet="true" name="twitter:image:alt" content="NICE and CKS logos"/><meta data-react-helmet="true" name="twitter:site" content="@NICEcomms"/><meta data-react-helmet="true" name="twitter:creator" content="@NICEcomms"/><meta data-react-helmet="true" name="theme-color" content="#004650"/><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+'';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer', 'GTM-54QC4NL');</script><link rel="manifest" href="../../../../manifest.webmanifest" crossorigin="anonymous"/><meta name="theme-color" content="#004650"/><link rel="apple-touch-icon" sizes="48x48" href="../../../../icons/icon-48x48.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="72x72" href="../../../../icons/icon-72x72.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="96x96" href="../../../../icons/icon-96x96.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="144x144" href="../../../../icons/icon-144x144.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="192x192" href="../../../../icons/icon-192x192.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="256x256" href="../../../../icons/icon-256x256.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="384x384" href="../../../../icons/icon-384x384.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="512x512" href="../../../../icons/icon-512x512.png@v=28734348209eeeae5c03a37867f1beb1"/><link as="script" rel="preload" href="../../../../webpack-runtime-28c424ef71f39faedaf0.js"/><link as="script" rel="preload" href="../../../../framework-34da02e39e1f104d9937.js"/><link as="script" rel="preload" href="../../../../app-53a71c38b210970893c4.js"/><link as="script" rel="preload" href="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js"/><link as="script" rel="preload" href="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js"/><link as="script" rel="preload" href="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"/><link as="fetch" rel="preload" href="../../../../page-data/topics/depression/management/new-or-initial-management/page-data.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/sq/d/3666801979.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/app-data.json" crossorigin="anonymous"/><script src="https://cdn.nice.org.uk/cookie-banner/cookie-banner.min.js" type="text/javascript" async=""></script></head><body><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54QC4NL" height="0" width="0" style="display: none; visibility: hidden" aria-hidden="true"></iframe></noscript><div id="___gatsby"><div style="outline:none" tabindex="-1" id="gatsby-focus-wrapper"><div><div class="Header-module--header--3os44"><header aria-label="Site header"><ul class="SkipLinks-module--list--1WwLa" aria-label="Accessibility links"><li><a href="index.html#content-start" class="SkipLinks-module--link--hkZw8">Skip to content</a></li><li><a href="https://www.nice.org.uk/accessibility" class="SkipLinks-module--link--hkZw8">Accessibility help</a></li></ul><div class="Header-module--container--1mfIr"><a href="https://www.nice.org.uk/" aria-label="Home" class="Header-module--home--1TCPb"><svg viewBox="0 0 4616 512" fill="none" class="Header-module--icon--4LSt5" aria-hidden="true" focusable="false"><path d="M1626 44v175h-22L1497 71v148h-19V44h22l107 147V44h19zm130 154a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-35 18-48 11-14 27-20 47-20 19 0 34 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm109 16V104h-27V87h27V40h19v47h30v17h-30v115h-19zm88-180v26h-21V39h21zm-20 48h20v132h-20V87zm107-2c20 0 35 6 48 20 11 12 17 28 17 48 0 19-6 36-17 48a61 61 0 01-48 20c-19 0-35-7-47-20a69 69 0 01-17-48c0-20 5-36 17-48 12-14 28-20 47-20zm0 118c14 0 25-5 34-15 7-9 11-21 11-35s-4-26-11-35c-9-10-20-15-34-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm107-116v21c5-7 11-12 18-17 6-4 14-6 23-6 8 0 16 1 22 4 6 2 12 6 17 11 10 10 16 24 16 42v77h-20v-76c0-13-3-22-10-29-7-8-16-11-26-11a38 38 0 00-40 40v76h-19V87h19zm222 111a52 52 0 01-46 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 5-35 17-48 12-14 27-20 47-20 19 0 35 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm114 16h-19V34h19v185zm108 0h-19V44h19v175zm55-132v21c5-7 10-12 17-17 7-4 15-6 23-6 9 0 17 1 23 4 6 2 12 6 16 11 11 10 16 24 16 42v77h-19v-76c0-13-4-22-10-29-7-8-16-11-27-11a38 38 0 00-39 40v76h-19V87h19zm202 35c-2-13-13-20-33-20s-30 6-30 19c0 5 2 9 6 12 5 2 10 5 16 6l21 5 21 7c7 2 12 6 16 11 5 5 7 11 7 19 0 13-5 23-15 30-9 7-22 10-38 10-18 0-32-4-42-13-9-8-14-18-15-31h20c2 13 8 21 21 25l13 2 13-1 11-3c8-3 12-9 12-17 0-5-2-9-6-12s-10-6-16-7l-21-5-21-7c-7-2-12-6-16-10-4-5-6-11-6-19 0-12 4-22 12-28 9-7 22-10 39-10 15 0 28 4 37 11 8 7 12 16 14 26h-20zm60 97V104h-26V87h26V40h20v47h30v17h-30v115h-20zm89-180v26h-21V39h21zm-21 48h20v132h-20V87zm65 132V104h-26V87h26V40h20v47h30v17h-30v115h-20zm162 0v-21c-4 7-10 12-17 16-7 5-14 7-23 7s-16-1-22-4c-7-2-12-6-17-11a57 57 0 01-16-42V87h20v76c0 12 3 22 10 29 6 7 15 11 26 11a39 39 0 0039-40V87h20v132h-20zm65 0V104h-26V87h26V40h20v47h30v17h-30v115h-20zm124-16c17 0 30-7 37-22h22c-5 12-12 22-22 29-9 7-22 11-38 11-19 0-35-7-47-20a68 68 0 01-18-48c0-20 5-36 17-48 12-14 28-20 47-20 20 0 35 6 48 20 11 12 17 28 17 48v8h-109c1 12 6 22 14 30s19 12 32 12zm-2-100c-12 0-22 4-30 11s-12 17-14 28h88c-1-11-6-21-14-28s-18-11-30-11zm195-52c-9 0-16 2-21 6-4 4-7 11-7 20v10h30v17h-30v115h-19V104h-23V87h23V75c0-14 4-25 12-32 9-7 21-11 36-11h1v19h-2zm75 34c19 0 35 6 47 20 12 12 18 28 18 48 0 19-6 36-18 48a61 61 0 01-47 20c-19 0-35-7-47-20a69 69 0 01-18-48c0-20 6-36 18-48 12-14 28-20 47-20zm0 118c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm156-118v20h-2c-14 0-25 5-34 17-9 11-13 24-13 39v58h-19V87h19v32c4-13 13-23 27-30 6-3 13-4 21-4h1zM1617 293v175h-19v-78h-101v78h-19V293h19v78h101v-78h19zm91 159c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c1 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm187 95a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-36 18-49 11-13 27-19 47-19 19 0 34 7 45 23v-21h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm114 16h-19V283h19v185zm46 0V353h-27v-17h27v-48h19v48h30v17h-30v115h-19zm87-185v73l17-16c7-4 15-6 24-6 8 0 16 1 22 3a58 58 0 0133 54v77h-20v-77c0-12-3-21-10-29-7-7-16-10-26-10a39 39 0 00-40 40v76h-19V283h19zm280 164a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm109-116v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 11 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10a39 39 0 00-39 40v76h-19V336h19zm222 111a52 52 0 01-47 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-74h19v185h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm233-1a56 56 0 0053-36h21c-6 17-15 30-28 39a82 82 0 01-50 16c-25 0-46-9-61-26a92 92 0 01-22-64c0-25 7-46 22-63 15-18 36-26 61-26a78 78 0 0178 54h-21c-4-11-11-19-20-25-10-7-20-10-33-10-12 0-22 2-30 5-9 4-15 9-21 15a73 73 0 00-17 50c0 21 6 37 17 50 12 14 29 21 51 21zm198-4a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 48-19 19 0 34 7 45 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm163-118v19h-2c-14 0-26 6-34 18-9 10-13 23-13 39v58h-19V336h19v32c4-14 13-24 27-30 6-3 13-4 21-4h1zm73 118c18 0 31-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-19 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 18-49s27-19 47-19c19 0 35 6 47 19s17 29 17 49v8h-109c2 12 7 22 15 30s19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm162-40v59h96v19h-96v59h108v19h-127V293h127v19h-108zm189 88l51 68h-25l-37-54-37 54h-25l51-68-48-64h25l34 50 33-50h25l-47 64zm120 52c9 0 16-3 23-7 6-5 11-11 14-19h21c-4 13-12 24-22 32-11 8-24 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19a60 60 0 0161 44h-20c-3-8-8-15-14-19-7-5-14-7-23-7-8 0-15 1-21 4-6 2-10 6-14 10-9 10-13 22-13 36s4 26 13 35c8 10 20 15 35 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-20 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 13-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm105 116h-19V283h19v185zm51 0h-20V283h20v185zm89-16c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c2 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm105-16v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 12 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10s-20 3-28 11c-7 7-11 17-11 29v76h-19V336h19zm185 116a40 40 0 0037-26h21c-4 13-12 24-22 32-11 8-25 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19c15 0 29 4 40 12 10 8 18 18 22 31h-21c-3-7-8-14-15-18-6-5-13-7-22-7-8 0-15 1-21 4-6 2-11 6-15 10-8 10-12 22-12 36s4 26 12 35c9 10 21 15 36 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 18 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-15 28h89c-2-11-6-21-14-28-8-8-18-11-30-11zM412 454c0 16-7 19-18 19h-53c-11 0-20-4-27-13L130 213h-2v242c0 13-6 18-18 18H52c-14 0-20-3-20-18V62c0-16 7-19 20-19h52c13 0 19 3 26 13l184 248h1V61c0-14 7-18 19-18h60c16 0 17 8 17 19v392h1zm197 4c0 7-5 14-14 14h-71c-9 0-14-7-14-14V56c0-8 5-15 14-15h71c9 0 14 7 14 14v403zm415-380l-18 52c-2 6-5 9-9 9l-8-2c-33-16-58-21-87-21-65 0-106 49-106 140 0 98 47 140 107 140 29 0 55-5 84-17l9-3c6 0 9 3 11 10l16 46 2 10c0 6-3 11-12 14-42 16-77 24-125 24-131 0-197-87-197-221S772 32 896 32c45 0 82 9 118 25 9 4 12 8 12 12l-2 9zm336-37c13 0 17 6 16 15l-6 50c-1 13-9 15-24 15h-149v93h140c14 0 19 7 19 17v45c0 12-7 18-18 18h-141v98h161c11 0 18 5 18 17v46c0 11-6 17-17 17h-240c-14 0-21-4-21-19V59c0-11 6-18 16-18h246z" fill="currentColor"></path></svg></a><div class="Header-module--wrapper--2e13D"><div class="Header-module--search--2nfnz"><form id="global-nav-search-form" role="search" action="https://cks.nice.org.uk/search" class="Search-module--search--2wNll"><label class="Search-module--label--1rrog" for="autocomplete">Search CKS</label><div class="Autocomplete-module--ac--2PqiF"><div class="autocomplete__wrapper"><input type="search" id="autocomplete" name="q" class="autocomplete__input autocomplete__input--default" placeholder="Search CKS" data-hj-allow="" maxLength="512" value=""/></div></div><button class="Search-module--button--2FbnI" type="submit" aria-label="Perform search"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="Search-module--icon--2JB42" aria-hidden="true" focusable="false"><path d="M83.784 476.472L197.112 363.16c30.144 20.32 65.056 30.528 100.032 30.528 45.904 0 91.776-17.488 126.8-52.528 70.064-70.064 70.064-183.584 0-253.616C388.936 52.504 343.048 35 297.144 35c-45.904 0-91.808 17.504-126.848 52.528-61.696 61.696-68.976 157.12-21.968 226.864L35 427.752l48.784 48.72zm213.36-137.952c-33.168 0-64.352-12.896-87.792-36.368-48.416-48.448-48.416-127.2 0-175.616 23.44-23.44 54.64-36.352 87.792-36.352s64.336 12.912 87.776 36.368c23.44 23.456 36.384 54.64 36.384 87.792s-12.928 64.352-36.384 87.792c-23.456 23.472-54.624 36.368-87.776 36.368v.016z" fill="currentColor"></path></svg></button></form></div><button class="Header-module--mobileMenuBtn--1LgyL" id="header-menu-button" type="button" aria-controls="header-menu" aria-expanded="false" aria-haspopup="menu" aria-label="Expand site menu">Menu</button></div></div><div id="header-menu" class="Nav-module--wrapper--2_xng Nav-module--wrapperWithSubLinks--3PUfX"><nav class="Nav-module--nav--2aQpa" aria-label="primary navigation"><div class="Nav-module--menuWrapper--2fp8S"><ul class="Nav-module--menuList--264L-" aria-labelledby="header-menu-button"><li><a href="https://pathways.nice.org.uk/" class="Nav-module--link--3JzDA">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Nav-module--link--3JzDA">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Nav-module--link--3JzDA">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Nav-module--link--3JzDA">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary">BNF<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Nav-module--link--3JzDA"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">Clinical Knowledge Summaries</span></a><div class="SubNav-module--wrapper--yAXWY"><ul class="SubNav-module--list--1K9bK" aria-label="CKS links"><li class="SubNav-module--imageLink--3xwIS"><a href="../../../../index.html" class="SubNav-module--link--39i23" aria-label="CKS - Home"><img src="data:image/svg+xml;base64,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" class="SubNav-module--image--uq-a2" alt=""/></a></li><li><a href="../../../index.html" class="SubNav-module--link--39i23" aria-label="Health topics A to Z">Health topics A to Z</a></li><li><a href="../../../../specialities/index.html" class="SubNav-module--link--39i23" aria-label="Specialities">Specialities</a></li><li><a href="../../../../whats-new/index.html" class="SubNav-module--link--39i23" aria-label="What&#x27;s new">What&#x27;s new</a></li><li><a href="../../../../about/index.html" class="SubNav-module--link--39i23" aria-label="About CKS">About CKS</a></li></ul></div></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Nav-module--link--3JzDA">Journals and databases</a></li></ul></div></nav></div></header><aside class="CoronaMessage-module--wrapper--zRiaV" aria-label="COVID-19 Notice"><div class="CoronaMessage-module--container--36Biz"><p>Read about<!-- --> <a href="https://www.nice.org.uk/covid-19">our approach to COVID-19</a></p></div></aside></div></div><main class="Layout-module--main--1OIFf" id="content-start"><div class="container"><nav aria-label="Breadcrumbs" role="navigation"><ol class="breadcrumbs"><li class="breadcrumbs__crumb"><a href="https://www.nice.org.uk/">NICE</a></li><li class="breadcrumbs__crumb"><a href="../../../../index.html">CKS</a></li><li class="breadcrumbs__crumb"><a href="../../../index.html">Health topics A to Z</a></li><li class="breadcrumbs__crumb"><a href="../../index.html">Depression</a></li><li class="breadcrumbs__crumb"><a href="../index.html">Management</a></li><li class="breadcrumbs__crumb"><span>Scenario: New or initial management</span></li></ol></nav><script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://www.nice.org.uk/","name":"NICE"}},{"@type":"ListItem","position":2,"item":{"@id":"/","name":"CKS"}},{"@type":"ListItem","position":3,"item":{"@id":"/topics/","name":"Health topics A to Z"}},{"@type":"ListItem","position":4,"item":{"@id":"/topics/depression/","name":"Depression"}},{"@type":"ListItem","position":5,"item":{"@id":"/topics/depression/management/","name":"Management"}},{"@type":"ListItem","position":6,"item":{"name":"Scenario: New or initial management"}}]}</script><div class="page-header"><h1 class="page-header__heading"><span class="page-header__pre-heading">Depression: </span><span>Scenario: New or initial management</span></h1><p class="page-header__lead"><span>Last revised in February 2021</span></p></div><p class="visually-hidden">Covers the initial management of a person with depression.</p><div class="ChapterContents-module--wrapper--3ONbu"><div class="ChapterContents-module--menu--3Epka"><nav class="stacked-nav" aria-label="Depression chapters"><ul class="stacked-nav__list"><li class="stacked-nav__list-item" data-tracking="Summary"><a aria-current="false" href="../../index.html"><span class="stacked-nav__content-wrapper">Summary</span></a></li><li class="stacked-nav__list-item" data-tracking="Have I got the right topic?"><a aria-current="false" href="../../have-i-got-the-right-topic/index.html"><span class="stacked-nav__content-wrapper">Have I got the right topic?</span></a></li><li class="stacked-nav__list-item" data-tracking="How up-to-date is this topic?"><a aria-current="false" href="../../how-up-to-date-is-this-topic/index.html"><span class="stacked-nav__content-wrapper">How up-to-date is this topic?</span></a></li><li class="stacked-nav__list-item" data-tracking="Goals and outcome measures"><a aria-current="false" href="../../goals-outcome-measures/index.html"><span class="stacked-nav__content-wrapper">Goals and outcome measures</span></a></li><li class="stacked-nav__list-item" data-tracking="Background information"><a aria-current="false" href="../../background-information/index.html"><span class="stacked-nav__content-wrapper">Background information</span></a></li><li class="stacked-nav__list-item" data-tracking="Diagnosis"><a aria-current="false" href="../../diagnosis/index.html"><span class="stacked-nav__content-wrapper">Diagnosis</span></a></li><li class="stacked-nav__list-item" data-tracking="Management"><a aria-current="false" href="../index.html"><span class="stacked-nav__content-wrapper">Management</span></a><ul class="stacked-nav__nested"><li class="stacked-nav__list-item" data-tracking="Management | Scenario: New or initial management"><a aria-current="true" class="" href="index.html"><span class="stacked-nav__content-wrapper">Scenario: New or initial management</span></a></li><li class="stacked-nav__list-item" data-tracking="Management | Scenario: Ongoing management"><a aria-current="false" href="../ongoing-management/index.html"><span class="stacked-nav__content-wrapper">Scenario: Ongoing management</span></a></li></ul></li><li class="stacked-nav__list-item" data-tracking="Prescribing information"><a aria-current="false" href="../../prescribing-information/index.html"><span class="stacked-nav__content-wrapper">Prescribing information</span></a></li><li class="stacked-nav__list-item" data-tracking="Supporting evidence"><a aria-current="false" href="../../supporting-evidence/index.html"><span class="stacked-nav__content-wrapper">Supporting evidence</span></a></li><li class="stacked-nav__list-item" data-tracking="How this topic was developed"><a aria-current="false" href="../../how-this-topic-was-developed/index.html"><span class="stacked-nav__content-wrapper">How this topic was developed</span></a></li><li class="stacked-nav__list-item" data-tracking="References"><a aria-current="false" href="../../references/index.html"><span class="stacked-nav__content-wrapper">References</span></a></li></ul></nav></div><div class="ChapterContents-module--onThisPage--1333P"><nav class="ChapterOnThisPage-module--wrapper--2zc7n" aria-labelledby="on-this-page"><h2 class="ChapterOnThisPage-module--heading--2SdDN" id="on-this-page">On this page</h2><ol class="ChapterOnThisPage-module--rootList--2II70" aria-label="Jump links to section on this page"><li><a href="index.html#assessment">Assessment</a><ol aria-label="Sections within Assessment" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class=""><a href="index.html#assessing-risk-of-suicide">Assessing risk of suicide</a></li><li class=""><a href="index.html#depression-questionnaires">Depression questionnaires</a></li><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-bf6">Basis for recommendation</a></li></ol></li><li><a href="index.html#management">Management</a><ol aria-label="Sections within Management" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class=""><a href="index.html#crisis-services">Crisis services</a></li><li class=""><a href="index.html#compulsory-admission">Compulsory admission</a></li><li class=""><a href="index.html#psychosocial-psychological-interventions">Psychosocial and psychological interventions</a></li><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-13c">Basis for recommendation</a></li></ol></li><li><a href="index.html#choosing-an-antidepressant">Choosing an antidepressant</a><ol aria-label="Sections within Choosing an antidepressant" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-0c3">Basis for recommendation</a></li></ol></li><li><a href="index.html#chronic-physical-health-problems">Chronic physical health problems</a><ol aria-label="Sections within Chronic physical health problems" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-f4c">Basis for recommendation</a></li></ol></li><li><a href="index.html#information-advice">Information and advice</a><ol aria-label="Sections within Information and advice" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-490">Basis for recommendation</a></li></ol></li><li><a href="index.html#follow-up">Follow up</a><ol aria-label="Sections within Follow up" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-c8e">Basis for recommendation</a></li></ol></li></ol></nav></div><div class="ChapterContents-module--body--1XBoo"><section aria-labelledby="new-or-initial-management" class="ChapterBody-module--wrapper--2HCfk "><h2 id="new-or-initial-management" class="visually-hidden">Scenario: New or initial management</h2><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item dfc76cdb-3598-460b-b8c0-0c1e37ed4534 --><!-- begin field 10b0de18-c54f-4e4b-bd2a-acd900ace252 --><p>From age 18 years onwards.</p><!-- end field 10b0de18-c54f-4e4b-bd2a-acd900ace252 --><!-- end item dfc76cdb-3598-460b-b8c0-0c1e37ed4534 --></div><section aria-labelledby="assessment" class="ChapterBody-module--wrapper--2HCfk "><h3 id="assessment">How should I assess someone with depression?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item bc62125d-ceb8-4fed-931c-4b411f75dd30 --><!-- begin field 5cc199e5-1cc4-4004-b08a-a70d009a362c --><p><strong>For people with depression, conduct a comprehensive assessment that does not rely simply on a symptom count take into account both the degree of functional impairment and/or disability associated with the depression and the duration of the episode.</strong></p><ul><li><strong>Assess the<a class="topic-reference internal-reference" href="index.html#assessing-risk-of-suicide">risk of suicide</a></strong> ask people directly about suicidal thoughts and intent.</li><li><strong>Consider any factors which may affect the development, course and severity of depression, including:</strong><ul><li>Any history of depression and comorbid mental health or chronic physical disorder.</li><li>Any past history of mood elevation (to determine if the depression may be part of bipolar disorder).</li><li>Any past experience of, and response to, treatments.</li><li>The quality of interpersonal relationships.</li><li>Living conditions and social isolation.</li><li>A family history of mental illness.</li><li>A history of domestic violence or sexual abuse.</li><li>Employment and immigration status.</li><li>Availability of social support.</li></ul></li><li><strong>Be aware ofany learning disabilities or acquired cognitive impairments</strong>, and if necessary consider consulting with a relevant specialist when developing treatment plans and strategies.</li><li><strong>Identify any safeguarding</strong>concerns for children or vulnerable adults in the care of someone with depression. Follow local safeguarding procedures if appropriate.</li><li><strong>Assess for any c</strong><strong>omorbid conditions associated with depression,</strong>including:<ul><li><strong>Alcohol or substance abuse</strong>for more information, see the CKS topic on<a class="topic-reference external-reference" href="../../../alcohol-problem-drinking/index.html">Alcohol - problem drinking</a>.</li><li><strong>Anxiety</strong>for more information, see the section on<a class="topic-reference external-reference" href="../../../generalized-anxiety-disorder/diagnosis/diagnosis/index.html">Detection</a>in the CKS topic on<a class="topic-reference external-reference" href="../../../generalized-anxiety-disorder/index.html">Generalized anxiety disorder</a>.</li><li><strong>Eating disorders</strong>for more information, see the CKS topic on<a class="topic-reference external-reference" href="../../../eating-disorders/index.html">Eating disorders</a>.</li><li><strong>Psychotic symptoms</strong>for more information, see the CKS topics on<a class="topic-reference external-reference" href="../../../psychosis-schizophrenia/index.html">Psychosis and schizophrenia</a>and<a class="topic-reference external-reference" href="../../../bipolar-disorder/index.html">Bipolar disorder</a>.</li><li><strong>Dementia</strong>for more information, see the CKS topic on<a class="topic-reference external-reference" href="../../../dementia/index.html">Dementia</a>.</li></ul></li><li><strong>Consider using a validated measure to inform and evaluatetreatment</strong>, such as a<a class="topic-reference internal-reference" href="index.html#depression-questionnaires">depression questionnaire</a>.<ul><li>For people with significant language or communication difficulties, consider using the Distress Thermometer and/or asking a family member or carer about the person's symptoms.<ul><li>The Distress Thermometeris a single-item question screen that identifiesdistress coming from any source. The person places a mark on the scale answering: 'How distressed have you been during the past week on a scale of 0 to 10?'. Scores of 4 or more indicate a significant level of distress that should be investigated further.</li></ul></li></ul></li></ul><!-- end field 5cc199e5-1cc4-4004-b08a-a70d009a362c --><!-- end item bc62125d-ceb8-4fed-931c-4b411f75dd30 --></div><section aria-labelledby="assessing-risk-of-suicide" class="ChapterBody-module--wrapper--2HCfk "><h4 id="assessing-risk-of-suicide">How do I assess the risk of suicide?</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 36523a8e-a32f-4542-a530-76b137960587 --><!-- begin field dd10dc1d-7a71-499f-816c-8c06e24042b2 --><ul><li><strong>When assessing the risk of suicide, ask the person:</strong><ul><li>Do you havethoughts about death or suicide?</li><li>Do you feel that life isnot worth living?</li><li>Have you made a previous suicide attempt?</li><li>Is there a family history of suicide?</li></ul></li><li><strong>If the answer to any of these questions is yes, askabout their plans for suicide:</strong><ul><li>Have you considered a method?</li><li>Do you have access to the materials?</li><li>Have you madeany preparations (for example, written anote)?</li></ul></li><li><strong>Also ask about any protective factors, for example:</strong><ul><li>What keeps you from harming yourself?</li><li>Is there anything that would make life worth living?</li></ul></li><li><strong>Identify risk factors that increase the risk of suicide  these include:</strong><ul><li>Previous suicide attempts orself-harm.</li><li>Active mental illness.</li><li>Family history of mental disorder, suicide or self-harm.</li><li>Male gender.</li><li>Being unemployed.</li><li>Physical health problems.</li><li>Living alone.</li><li>Being unmarried.</li><li>Drug/alcohol dependence.</li><li>Feelings of hopelessness.</li><li>Exposure to suicidal behaviour.</li></ul></li><li><strong>High risk groups include:</strong><ul><li>Young and middle-aged men.</li><li>People in contact with the criminal justice system.</li><li>Specific occupational groups, for example, doctors, nurses, veterinary workers, farmers, agricultural workers.</li></ul></li><li><strong>If there is a risk of self-harm or suicide:</strong><ul><li>Assess whether the person has adequate social support and is aware of sources of help.</li><li>Assess whether there are any dynamic risk factorsthat can be treated (for example, mental illness, use of alcohol or illicit drugs).</li><li>Arrange help appropriate to the level of risk.</li><li>Advise the person to seek further help if the situation deteriorates.</li></ul></li><li><strong>If a person with depression presents considerable immediate risk to themselves or others, refer them urgently to specialist mental health services.</strong></li><li><strong>If the person is considered at low risk, discuss and/or create a safety plan with them, detailing steps they shouldtake if their situation deteriorates.</strong></li></ul><style type="text/css">//<![CDATA[//<![CDATA[//]]>////]]>//</style><!-- end field dd10dc1d-7a71-499f-816c-8c06e24042b2 --><!-- end item 36523a8e-a32f-4542-a530-76b137960587 --></div></section><section aria-labelledby="depression-questionnaires" class="ChapterBody-module--wrapper--2HCfk "><h4 id="depression-questionnaires">Depression questionnaires</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 4c7f214d-a252-4e33-bc02-a7a7011f9ab7 --><!-- begin field f4d6c622-dc1f-4fe9-8510-a7a7011f9d34 --><ul><li>Depression questionnaires can be helpful in detecting depression and in assessing severity, but should not be used alone to determine the presence of depression which needs treatment.</li><li>The three recommended questionnaires, which are validated for use in primary care, are PHQ-9 (Patient Health Questionnaire 9), HADS (Hospital Anxiety and Depression Scale), and BDI-II (Beck Depression Inventory-II).<ul><li><strong>PHQ-9</strong><ul><li>A nine-item, self-administered scale, which reflects the DSM-5(Diagnostic and Statistical Manual of Mental Disorders, fourth edition) criteria.</li><li>It classifies current symptoms on a scale of 0 (not at all)to 3 (nearly every day)  the maximum score is 27.</li><li>Scores of 5, 10, 15, and 20 represent cut off points for mild, moderate, moderately severe and severe depression, respectively.</li><li>It can be downloaded free of charge from <a href="https://www.phqscreeners.com/select-screener" data-hyperlink-id="cd3361d0-a8de-4ac7-a550-aa9900bb023f">www.phqscreeners.com</a>.</li></ul></li><li><strong>HADS</strong><ul><li>A self-administered scale, with 14 questionsin total (seven covering depression and seven covering anxiety).</li><li>The maximum score for each subscale is 21.</li><li>Scores of 8-10, 11-14, and 15-21 represent cut off points for mild, moderate and severe depression respectively.</li><li>A paper version is available to purchase from<a href="https://www.gl-assessment.co.uk/products/hospital-anxiety-and-depression-scale-hads/" data-hyperlink-id="4e341924-6088-4ea9-850b-ab1901010c51">https://www.gl-assessment.co.uk/products/hospital-anxiety-and-depression-scale-hads/</a>as an online version is no longer available.</li></ul></li><li><strong>BDI-II</strong><ul><li>A 21-item, self-administered scale that uses DSM-5criteria.</li><li>Each question is rated from 0 to 3 the maximum score is 63.</li><li>Scores of 14-19,20-28, and 29-63 can be interpreted as mild, moderate, and severe depression respectively.</li><li>It is available to purchase from<a href="http://www.pearsonassessments.com/" data-hyperlink-id="8ca9387a-d783-4ef0-8da2-a9910049e7bc">www.pearsonassessments.com</a>.</li></ul></li></ul></li></ul><!-- end field f4d6c622-dc1f-4fe9-8510-a7a7011f9d34 --><!-- end item 4c7f214d-a252-4e33-bc02-a7a7011f9ab7 --></div></section><section aria-labelledby="basis-for-recommendation-bf6" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-bf6">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item bf65bf1b-acd3-4164-8662-a70700fef409 --><!-- begin field c841d86b-03bb-4894-aa22-a70700fef509 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidelines<em>Depression: the treatment and management of depression in adults</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>],<em>Common mental health disorders: identification and pathways to care</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2011</a>],a Canadian guideline from the British Columbia Medical Association (BCMA)<em>Major depressive disorder in adults: diagnosis & management </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">BCMA, 2013</a>],expert opinion innarrative reviews<em>Exploring thoughts of suicide</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">Sinclair, 2017</a>], and<em>Can we usefully stratify patients according to suicide risk?</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">Large, 2017</a>], a US guideline from the Institute for Clinical Systems Improvement (ICSI)<em>Depression in primary care</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">ICSI, 2016</a>], and the HM Government document <em>Preventing suicide in England: Fourth progress report of the cross-government outcomes strategy to save lives</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">HM Government, 2019</a>].</p><h5>Assessing the risk of suicide</h5><ul><li>The recommendation to ask people with depression directly about suicidal ideation and intent is based on the NICE guideline [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>].</li><li>However, a review of seven meta-analyses of studies among psychiatric patients or people presenting with self harm[<a class="bibliography-reference internal-reference" href="../../references/index.html">Large, 2017</a>]found that there arenot any individual clinical risk factors, includingsuicidal thoughts and behaviours, that are sufficiently accurate to be useful as the basis to allocate interventions.<ul><li>No high risk determination, whether based on a model that integrated multiple risk factors or a suicide risk scale, was strongly associated with later death by suicide. Moreover, almost half of all people who die by suicide come from lower risk strata, indicating a low sensitivity in high risk status.</li><li>The overwhelming majority of people who might be viewed as at high risk of suicide will not die by suicide.</li></ul></li><li>A meta-analysisthat looked at risk factors for self harm as well as suicide found only four risk factors with strong evidence to support them [<a class="bibliography-reference internal-reference" href="../../references/index.html">Chan, 2016</a>]:<ul><li>Previous episodes of self harm.</li><li>Male gender.</li><li>Being unemployed.</li><li>Having physical health problems.</li></ul></li><li>The UK National Confidential Inquiry into suicides identified four additional risk factors [<a class="bibliography-reference internal-reference" href="../../references/index.html">University of Manchester, 2018</a>]:<ul><li>Living alone.</li><li>Being unmarried.</li><li>Drug/alcohol dependence.</li><li>Active mental illness.</li></ul></li><li>The HM Government document<em>Preventing suicide in England: Fourth progress report of the cross-government outcomes strategy to save lives</em>, identified the following high-risk groups [<a class="bibliography-reference internal-reference" href="../../references/index.html">HM Government, 2019</a>]:<ul><li>Young and middle-aged men.</li><li>People in the care of mental health services, including inpatients.</li><li>People in contact with the criminal justice system.</li><li>Specific occupational groups, such as doctors, nurses, veterinary workers, farmers and agricultural workers.</li><li>People with a history of self-harm.</li></ul></li></ul><p><strong>Consider comorbid medical conditions</strong>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>]</p><ul><li>The recommendation to considera history of depression and comorbid mental health or physical disorders is based on the NICEguideline which states that suicideis commonest in those with comorbid physical and mental illness.<style type="text/css">//<![CDATA[//]]>//</style></li></ul><!-- end field c841d86b-03bb-4894-aa22-a70700fef509 --><!-- end item bf65bf1b-acd3-4164-8662-a70700fef409 --></div></section></section><section aria-labelledby="management" class="ChapterBody-module--wrapper--2HCfk "><h3 id="management">How should I manage depression in primary care?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item e7084a5c-934b-4100-9c89-a70700ff0b0d --><!-- begin field 93ce43ba-2555-4e1a-88eb-a70700ff0c01 --><ul><li><strong>Manage suicide risk.</strong>Options include:<ul><li>Contacting the Crisis Resolution and Home Treatment <a class="topic-reference internal-reference" href="index.html#crisis-services">(CRHT)</a>team for an urgent assessment.<ul><li>Voluntary admission or <a class="topic-reference internal-reference" href="index.html#compulsory-admission">compulsory admission</a>may be required.</li></ul></li><li>Reviewing a person frequently in primary care.</li></ul></li><li><strong>Manage any safeguarding concerns</strong>for children or vulnerable adults in their care. Follow local safeguarding procedures if appropriate.</li><li><strong>Manage any comorbid condition associated with depression</strong>,such as:<ul><li><strong>Alcohol or substance abuse</strong>treat the underlying drinking or substance problem; depressive symptoms frequently resolve following this. For more information, see the CKS topic on<a class="topic-reference external-reference" href="../../../alcohol-problem-drinking/index.html">Alcohol - problem drinking</a>.</li><li><strong>Anxiety</strong>where depression is accompanied by anxiety, the first priority should usually be to treat the depression. For information on treatingpeople with anxiety see the CKS topic on<a class="topic-reference external-reference" href="../../../generalized-anxiety-disorder/index.html">Generalized anxiety disorder</a>.</li><li><strong>Psychotic symptoms</strong>seek expert advice. The use of antidepressants in people with bipolar disorder can trigger hypomania/mania. For more information, see the CKS topics on<a class="topic-reference external-reference" href="../../../psychosis-schizophrenia/index.html">Psychosis and schizophrenia</a>and<a class="topic-reference external-reference" href="../../../bipolar-disorder/index.html">Bipolar disorder standard</a>.</li><li><strong>Eating disorders</strong>seek expert advice. For more information, see the CKS topic on<a class="topic-reference external-reference" href="../../../eating-disorders/index.html">Eating disorders</a>.</li><li><strong>Dementia</strong> for people with mild to moderate dementia who have mild to moderate depression, consider psychological treatments, but do not routinely offer antidepressants to manage mild to moderate depression in people with mild to moderate dementia.Unless they are indicated for a pre-existing severe mental health problem, treat the underlying depression. For more information, see the CKS topic on<a class="topic-reference external-reference" href="../../../dementia/index.html">Dementia</a>.</li></ul></li><li><strong>For people with mild depression who do not want an intervention, or people with subthreshold depressive symptoms who request an intervention,consider a period ofactive monitoring, and:</strong><ul><li>Discuss the presenting problems and any concerns theymay have.</li><li>Provide information about the nature and course of depression.</li><li>Arrange <a class="topic-reference internal-reference" href="index.html#follow-up">follow up</a>, normally within 2weeks (consider contacting the person if they do not attend follow-up appointments).</li></ul></li><li><strong>For people with persistent subthreshold depressive symptoms or mild-to-moderate depression:</strong><ul><li>Consider offering a<a class="topic-reference internal-reference" href="index.html#psychosocial-psychological-interventions">low-intensity psychosocial intervention</a> this is accessed by referral or self-referral toIAPT(Improving Access to Psychological Therapies). </li><li>Consider group-based CBT for people who decline low intensity psychosocial interventions.</li><li>Avoid the routine use of<a class="topic-reference internal-reference" href="index.html#choosing-an-antidepressant">antidepressants</a>, but consider this for people with:<ul><li>A history of moderate or severe depression.</li><li>Subthreshold depressive symptoms that have persisted for a long period (typically at least 2years).</li><li>Subthreshold symptoms or mild depression that persists after other interventions.</li><li>Mild depression that is complicating the care of a chronic physical health problem.</li></ul></li></ul></li><li><strong>For people with moderate or severe depression</strong>offer anantidepressant anda<a class="topic-reference internal-reference" href="index.html#psychosocial-psychological-interventions">high-intensity psychological intervention</a>.Psychological interventions are accessed by referral or self-referral toIAPT. The type of intervention offered will depend on the severity of depression, the response to any previous treatment, the likelihood of adherence totreatment and potential adverse effects, and the person's preferences and priorities.</li><li><strong>For peoplestarting an antidepressant:</strong><ul><li>Consider suicide risk and toxicity in overdose.</li><li>Explain that symptoms of anxiety may initially worsen.</li><li>Explain that antidepressants take time to work.</li><li>Explain that antidepressants should be continued for at least 6 months following remission of symptoms, as this greatly reduces the risk of relapse.</li></ul></li><li><strong>For people having difficulty sleeping, </strong>offer sleep hygiene advice. For more information, see the section on<a class="topic-reference external-reference" href="../../../insomnia/management/managing-short-term-insomnia-less-3-months/index.html#good-sleep-hygiene">Good sleep hygiene</a>in the CKS topic on<a class="topic-reference external-reference" href="../../../insomnia/index.html">Insomnia</a>.</li><li><strong>Arrange<a class="topic-reference internal-reference" href="index.html#follow-up">follow up</a></strong>to assess the response to treatment, the need for further management, and for any adverse effects or compliance issues associated with anti-depressants.</li><li><strong>Provide<a class="topic-reference internal-reference" href="index.html#information-advice">information and advice</a></strong>about depression and its treatment.</li><li><strong>Manage people with </strong><strong>seasonal</strong><strong> affective disorder</strong>the same way as other people with depression.</li></ul><!-- end field 93ce43ba-2555-4e1a-88eb-a70700ff0c01 --><!-- end item e7084a5c-934b-4100-9c89-a70700ff0b0d --></div><section aria-labelledby="crisis-services" class="ChapterBody-module--wrapper--2HCfk "><h4 id="crisis-services">Crisis services</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 48bfe117-17b6-4c9b-be14-a7a7011b8986 --><!-- begin field f3f1ccf3-dbb8-4049-a69c-a7a7011b8bc3 --><ul><li>Crisis resolution and home treatment (CRHT) teams usually include a psychiatrist, mental health nurses, social workers and support workers and are available 24 hours a day, 7days a week.</li><li>The CRHT team assesses the person's needs, manages the risks of being at home, assists with self-help strategies, visits frequently, offers psychological and practical help, and administers medication.</li><li>While there is insufficient evidence to clearly support their use in depression, the National Institute for Health and Clinical Excellence (NICE) advises that crisis teams may have a role for a small number of people with depression who require more intensive care.</li></ul><p>[<a class="bibliography-reference internal-reference" href="../../references/index.html">Mind, 2018</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>] </p><!-- end field f3f1ccf3-dbb8-4049-a69c-a7a7011b8bc3 --><!-- end item 48bfe117-17b6-4c9b-be14-a7a7011b8986 --></div></section><section aria-labelledby="compulsory-admission" class="ChapterBody-module--wrapper--2HCfk "><h4 id="compulsory-admission">Compulsory admission</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 4848c80d-0df7-4764-8183-a7a700f255ac --><!-- begin field e09f9d7a-583a-4396-b2db-a7a700f257f4 --><ul><li><strong>If the person needs to be admitted to </strong><strong>hospital</strong><strong>,</strong>every attempt should be made to persuade them to go voluntarily.</li><li><strong>If admission is necessary but the person declines,</strong>compulsory admission may be arranged under sections2,3, or4 of the Mental Health Act.</li><li><strong>The Mental Health Act allows compulsory admission</strong>of people who:<ul><li>Have a mental disorder of a nature or degree that warrants assessment or treatment in hospital,and</li><li>Need to be admitted in the interests of their own health or safety, or for the protection of other people.</li></ul></li><li><strong>Compulsory admission is arranged using the appropriate section of the Mental Health Act.</strong><ul><li><strong>Section2 allows compulsory admission for up to 28days for assessment.</strong></li><li><strong>Section3 allows compulsory admission for up to 6months for treatment.</strong><ul><li>Sections2 and3 require an application from an approved mental health professional, or the person's nearest relative, andwritten recommendations from two doctors; one of whom is section12 approved (usually a psychiatrist) and one who has previous acquaintance with the individual (usually the person's GP if at all practicable).</li><li>For admission under section2, where there is no obvious person to provide the second medical recommendation (for example because the person is not registered with a GP or is not known to local mental health services), another section12-approved doctor is usually asked to assess the individual. However, in cases where this is not practicable,any registered medical practitionermay provide the second recommendation as long as there are no potential conflicts of interest (for example, they work in the same hospital as the doctor providing the first recommendation).</li><li>The person can be examined jointly or separately by the two doctors.</li></ul></li><li><strong>Section4 is used in exceptional cases to permit compulsory admission for up to 72hours</strong>if there is urgent necessity, and undesirable delay would occur while trying to arrange admission under normal procedures.<ul><li>It requires an application from an AMHP (or the person's nearest relative) and just one medical recommendation, preferably from a doctor with previous acquaintance (usually the GP).</li><li>Where the person has been compulsorily admitted under an emergency section4, this section is usually converted to a section2 (usually requiring further involvement of the GP).</li></ul></li><li><strong>Section136 may be used by police to take people from a public place to a place of safety</strong><strong>so they can be assessed.</strong></li></ul></li><li>Young people aged 16or 17years who have capacity to consent, but refuse to do so, cannot be admitted or kept in hospital for treatment for a mental disorder on the basis of their parents' consentthey will need to be formally detained under the Mental Health Act.</li><li>Guidance and forms for the most common sections of the Mental Health Act can be accessed from the<a data-hyperlink-id="162b1626-4056-41a6-8f45-a9910049e5e2" href="https://www.gov.uk/government/organisations/department-of-health">Department of Healthwebsite</a>, and a <a data-hyperlink-id="c45945cc-f119-443e-96a6-ab200100c968" href="https://www.gov.uk/government/publications/mental-health-act-1983-reference-guide">reference guide to the Mental Health Act 1993</a> is also available.</li></ul><p>[<a class="bibliography-reference internal-reference" href="../../references/index.html">DH, 2015</a>]</p><!-- end field e09f9d7a-583a-4396-b2db-a7a700f257f4 --><!-- end item 4848c80d-0df7-4764-8183-a7a700f255ac --></div></section><section aria-labelledby="psychosocial-psychological-interventions" class="ChapterBody-module--wrapper--2HCfk "><h4 id="psychosocial-psychological-interventions">Psychosocial and psychological interventions</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 73f7cd0f-4736-4cb6-be8b-a7a701236786 --><!-- begin field 766e7115-f46b-402d-996b-a7a7012369ae --><ul><li><strong>Low-intensity psychosocial interventions</strong>are suitable for people with persistent subthreshold depressive symptoms or mild depression, and include:<ul><li>Individual guided self-help, based on the principles of cognitive behavioural therapy (CBT)  this includes written material or other media relevant to reading age, andusually consists of 68sessions (face-to-face and via telephone) over 912weeks.</li><li>Computerized cognitive behavioural therapy (CCBT) this can be provided via a stand-alone computer-based or web-based programme and usually takes place over 912weeks.</li><li>Structured group-based physical activity programmeusually consists of 3sessions per week of moderate duration (45minutes to 1hour) over 1014 weeks.</li></ul></li><li><strong>Group-based CBT </strong>is suitablefor people with persistent subthreshold depressive symptoms or mild to moderate depression who decline low-intensity psychosocial interventions  usually consists of 1012 meetings of 810 participants over 1216weeks.</li><li><strong>High-intensity psychological interventions</strong>are generally reserved for people with moderate-to-severe depression, and include:<ul><li>Individual CBTusually given over 1620sessions over 34months. For people with severe depression, two sessions per week might be provided for the first 23weeks of treatment.</li><li>Interpersonal therapyduration and number of sessions is similar to CBT.</li><li>Behavioural activationduration and number of sessions is similar to CBT.</li><li>Couples therapyusually consists of 1520sessions over 56months.</li></ul></li><li><strong>Counselling and short-term psychodynamictherapy</strong>  thesecan be considered for people who decline antidepressants and high-intensity psychological interventions.<ul><li>Counselling is usually provided in 610sessions over a period of 812weeks.</li><li>Short-term psychodynamic therapy usually consists of 1620sessions over 46months.</li><li>Discuss with the person the uncertainty of the effectiveness of these options.</li></ul></li></ul><p>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>]</p><!-- end field 766e7115-f46b-402d-996b-a7a7012369ae --><!-- end item 73f7cd0f-4736-4cb6-be8b-a7a701236786 --></div></section><section aria-labelledby="basis-for-recommendation-13c" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-13c">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 13c19bb1-70c8-4386-aa6f-a70700ff0c06 --><!-- begin field 5dfc7cee-07bd-4f0b-a4ec-a70700ff0c06 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidelines<em>Depression: the treatment and management of depression in adults</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>],<em>Common mental health disorders: identification and pathways to care</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2011</a>], <em>Depression in adults with a chronic physical health problem</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2009</a>],<em>Eating disorders: recognition and treatment </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2017</a>], and<em>Dementia: assessment, management and support for people living with dementia and their carers</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE, 2018</a>], the ScottishIntercollegiate Guidelines Network (SIGN) guideline<em>The management of harmful drinking and alcohol dependence in primary care</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">SIGN, 2003</a>], the Department of Health (DH)<em>Reference guide for the Mental Health Act 1993</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">DH, 2015</a>], the University of Oxford's Centre for Suicide Research (CSR) guideline <em>Assessment of suicide risk in people with depression</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">CSR, 2013</a>],and what CKS consider good clinical practice.</p><!-- end field 5dfc7cee-07bd-4f0b-a4ec-a70700ff0c06 --><!-- end item 13c19bb1-70c8-4386-aa6f-a70700ff0c06 --></div></section></section><section aria-labelledby="choosing-an-antidepressant" class="ChapterBody-module--wrapper--2HCfk "><h3 id="choosing-an-antidepressant">Which antidepressant should I prescribe?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 56260e13-4869-462c-abea-a70700ff4412 --><!-- begin field 3fb91554-0160-4eef-8d6b-a70700ff4503 --><ul><li><strong>When choosing an antidepressant, take into consideration:</strong><ul><li>The person's preference.</li><li><a class="topic-reference internal-reference" href="../../prescribing-information/toxicity-in-overdose/index.html">Toxicity in overdose</a> avoid tricyclic antidepressants or venlafaxine if there is a history, or likelihood, of overdose.</li><li>The adverse effectprofilefor example, sedation, sexual adverse effects, weight gain.</li><li>Any associated psychiatric disorderor concurrent medical illness or condition.</li><li>Current drug treatments that mayinteractwith antidepressant drugs, including any over the counter medication, herbal remedies or illegal drugs.</li><li>For more information, see the sections on contraindications and cautions, adverse effects and drug interactionsin the section on<a class="topic-reference internal-reference" href="../../prescribing-information/index.html">Prescribing information</a>.</li></ul></li><li><strong>Although the above factors may influence the choice of antidepressant, in general:</strong><ul><li><strong>If this is </strong><strong>a first</strong><strong> episode of depression</strong>,consider:<ul><li>Prescribing a generic selective serotonin reuptake inhibitor (SSRI), such as citalopram, fluoxetine, paroxetine, or sertraline.</li></ul></li><li><strong>If this is a recurrent episode of depression,consider:</strong><ul><li>Prescribing an antidepressant that the person has had a good response to previously.</li><li>Avoiding antidepressants that the person has previously failed to respond to or could not tolerate.</li></ul></li><li>If the person has a chronic physical health problem:<ul><li>Sertraline may be preferred, because it has a lower risk of drug interactions.</li><li>If an SSRI is prescribed, consider gastroprotection in older people who are taking nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin.</li></ul></li></ul></li><li>For information regarding the use of antidepressants in women who are pregnant or breastfeeding, see the CKS topic on<a class="topic-reference external-reference" href="../../../depression-antenatal-postnatal/index.html">Depression - antenatal and postnatal</a>.</li></ul><style type="text/css">//<![CDATA[//<![CDATA[//]]>////]]>//</style><!-- end field 3fb91554-0160-4eef-8d6b-a70700ff4503 --><!-- end item 56260e13-4869-462c-abea-a70700ff4412 --></div><section aria-labelledby="basis-for-recommendation-0c3" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-0c3">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 0c3da2d7-f100-48e1-882a-a70700ff4508 --><!-- begin field 1016fc01-091a-4ea0-b5f7-a70700ff4508 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidelines<em>Depression: the treatment and management of depression in adults</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>], <em>Depression in adults with a chronic physical health problem</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2009</a>], theBritish Association for Psychopharmacology<em> Evidence-based guidelines for treating depressive disorders with antidepressants: arevision of the 2008 British Association for Psychopharmacology guidelines </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">Cleare, 2015</a>], and theMedicines and Healthcare products Regulatory Agency (MHRA) drug safety update<em>Citalopram: suspected drug interaction with cocaine; prescribers should consider enquiring about illicit drug use</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2016</a>].</p><p><strong>Choice of antidepressant</strong>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>]</p><ul><li>NICE concluded that the efficacy of the different antidepressants is largely equivalent.<ul><li>It found no evidence that newer antidepressants such as escitalopram, duloxetine, or venlafaxine are more effective than other antidepressants the choice of antidepressant should depend on adverse effect profiles, the person's preference, previous experience of treatments, likelihood to cause discontinuation symptoms, and safety in overdose.</li><li>A generic selective serotonin reuptake inhibitor (SSRI) is preferred as they have a better adverse effect profile than other antidepressants and are less toxic in overdose.</li></ul></li><li>NICE recommends that citalopram and sertraline may be preferred in people with a chronic physical health problem because they have a lower propensity for drug interactions [<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2009</a>].</li><li>HoweverCKS recommends sertraline as the preferred antidepressant for people with a chronic physical health problem.<ul><li>Citalopram and escitalopram have been found to prolong the QT interval and should be avoided in people with congenital long QT interval or who have pre-existing QT interval prolongation, or in people who are already taking medication known to prolong the QT interval as there may be an additive effect [<a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2014a</a>].</li></ul></li><li>A recent systematic reviewand network meta-analysis of 522 double-blind parallel randomized controlled trials (n = 116,477) which compared the effectiveness and acceptability of 21 antidepressants against each other or placebo in people with moderate to severe depression[<a class="bibliography-reference internal-reference" href="../../references/index.html">Cipriani, 2018</a>] found that escitalopram, mirtazapine, paroxetine, agomelatine, and sertraline had a relatively higher response and lower dropout rate than the other antidepressants. By contrast, reboxetine, trazodone, and fluvoxamine were associated with generally inferior efficacy and acceptability profiles compared with the other antidepressants.<ul><li>However, in head to head studies when all data were considered, overall it found few differences between antidepressants, and there was more diversity in the range of efficacy and dropout patterns seen across the head-to-head comparisons than the meta-analysis of antidepressants versus placebo.</li></ul></li></ul><style type="text/css">//<![CDATA[//<![CDATA[//]]>////]]>//</style><!-- end field 1016fc01-091a-4ea0-b5f7-a70700ff4508 --><!-- end item 0c3da2d7-f100-48e1-882a-a70700ff4508 --></div></section></section><section aria-labelledby="chronic-physical-health-problems" class="ChapterBody-module--wrapper--2HCfk "><h3 id="chronic-physical-health-problems">Which antidepressants are recommended for people with chronic physical health problems?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item f87508b4-8985-4c1c-a7f6-ab2501111e31 --><!-- begin field 2e2d64b7-f8d1-443a-96de-ab2501111e9b --><ul><li>Prescribea generic selective serotonin reuptake inhibitor (SSRI), such as sertraline or citalopramunless these arecontraindicatedor there is a significantdrug interaction.<ul><li>Do not use citalopram or escitalopram in people who are taking medication that could prolong the QT interval.</li></ul></li><li>For a brief summary on which antidepressants may be prescribed for people with chronic physical health problems, seeTable 1. For more detailed information see appendix16 of the full<a href="https://www.nice.org.uk/guidance/CG91" data-hyperlink-id="a34f7975-6a05-4ac4-8e2c-a98f0161c2f4">NICE guideline</a>.</li></ul><p><strong>Table 1. </strong>Antidepressants recommended for people with a chronic physical health problem.</p><table data-table-id="4eea3f51-4154-4e98-8316-acce014f8f06"><thead><tr><th scope="col">Medication being taken for a chronic physical health problem</th><th scope="col">Antidepressants that should not normally be offered</th><th scope="col">Suitable options</th></tr></thead><tbody><tr><td>Nonsteroidal anti-inflammatory drugs (NSAIDs)</td><td>Selective serotonin reuptake inhibitor (SSRI) or a serotonin noradrenaline reuptake inhibitor (SNRI) (if no suitable alternative can be found, offer gastroprotection)</td><td>Mirtazapine, moclobemide, reboxetine, or trazodone</td></tr><tr><td>Warfarin</td><td>Tricyclic antidepressants (TCAs), SSRIs, or SNRIs</td><td>*Mirtazapine, reboxetine, trazodone, or mianserin</td></tr><tr><td>Heparin</td><td>SSRI or an SNRI</td><td>Any alternative (for example mirtazapine, trazodone, reboxetine, or a TCA).</td></tr><tr><td>Aspirin</td><td>SSRIs and SNRIs (if no suitable alternative can be found, offer gastroprotection)</td><td><p>Mirtazapine.</p><p>When aspirin is used alone, consider trazadone or reboxetine.</p></td></tr><tr><td>Anti-epileptic drugs</td><td>All antidepressants lower the seizure threshold  seek specialist advice.Consider whether depression may be worsened by the anti-epileptic drug.</td><td><p>SSRIs: sertraline (preferred option)</p><p>Fluoxetine and fluvoxamine (not best options due to increased risk of drug interactions)</p><p>Moclobemide (second choice after SSRIs)</p><p>TCAs use cautiously(doxepin may havelowest risk of seizures)</p></td></tr><tr><td>Triptan drugs for migraine</td><td>Do not offer SSRIs.</td><td>Mirtazapine, trazadone, mianserin, or reboxetine.</td></tr><tr><td>MAO-B inhibitors (such as selegiline and rasagiline)</td><td>SSRIs.</td><td>Mirtazapine, trazadone, mianserin, or reboxetine.</td></tr><tr><td>Clozapine, methadone, tizanidine</td><td><p>Fluvoxamine.</p><p>Do not offer citalopram or escitalopram</p></td><td>Sertraline</td></tr><tr><td>Theophylline</td><td>Fluvoxamine.</td><td><br>Sertraline or citalopram</td></tr><tr><td>Flecainide or propafenone</td><td>Do not offer citalopram or escitalopram</td><td><p>Sertraline (preferred option)</p><p>Mirtazapine or moclobemide may also be used</p></td></tr><tr><td>Atomoxetine</td><td>Do not offer fluoxetine, paroxetine, citalopram, or escitalopram</td><td>A different SSRI.</td></tr><tr><td colspan="3"><p><strong>Data from:</strong>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2009</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2014a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">SPS, 2019a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Joint Formulary Committee, 2019</a>] * INR may increase slightly.</p></td></tr></tbody></table><!-- end field 2e2d64b7-f8d1-443a-96de-ab2501111e9b --><!-- end item f87508b4-8985-4c1c-a7f6-ab2501111e31 --></div><section aria-labelledby="basis-for-recommendation-f4c" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-f4c">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item f4cb7728-fcda-4ce9-9431-ab2501111ea1 --><!-- begin field 6ec53523-31a1-4617-88d0-ab2501111ea2 --><p>These recommendationsare based on the National Institute for Health and Care Excellence (NICE) guideline<em>Depression in adults with a chronic physical health problem</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2009</a>], the Medicines and Healthcare products Regulatory Agency (MHRA) drug safety update<em>Citalopram and escitalopram: QT interval prolongation</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2014a</a>], the Specialist Pharmacy Service (SPS) document <em>What is the most appropriate antidepressant to use in people with epilepsy?</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">SPS, 2019a</a>]and the <em>British National Formulary</em> (BNF)[<a class="bibliography-reference internal-reference" href="../../references/index.html">Joint Formulary Committee, 2019</a>].</p><!-- end field 6ec53523-31a1-4617-88d0-ab2501111ea2 --><!-- end item f4cb7728-fcda-4ce9-9431-ab2501111ea1 --></div></section></section><section aria-labelledby="information-advice" class="ChapterBody-module--wrapper--2HCfk "><h3 id="information-advice">What information and advice should I provide about depression?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 73afab8f-b298-425a-8bd1-a70700ff57bc --><!-- begin field 83efccd8-5aa3-4a80-ae9c-a70700ff5948 --><ul><li><strong>Give advice about guided self-help groups, support groups and other local and national resources.</strong><strong>Guided self-help may include:</strong><ul><li>Self-help leaflets or books, using cognitive behavioural therapy principles.</li><li>Self-help computer programmes or the internet.</li><li>Exercise sessions (three each week for up to 1 hour), for 1012 weeks.</li></ul></li><li><strong>Organizations</strong><strong> that offer materials and/or support to people with depression include:</strong><ul><li>MIND<a data-hyperlink-id="b5fdf9ba-706c-45de-a31e-a98f015daf85" href="http://www.mind.org.uk/">www.mind.org.uk</a>.</li><li>Depression Alliance<a data-hyperlink-id="3b9aab09-b301-4cf0-b131-a98f015dafbb" href="http://www.depressionalliance.org/">www.depressionalliance.org</a>.</li><li>Depression UK<a data-hyperlink-id="954d4cd2-1fb1-4cd5-9ce2-a98f015db088" href="http://www.depressionuk.org/">www.depressionuk.org</a>.</li><li>Mental Health Foundation<a data-hyperlink-id="0ea01d87-7105-4d6b-9662-a98f015db535" href="http://www.mentalhealth.org.uk/">www.mentalhealth.org.uk</a>.</li><li>Samaritanstelephone helpline: 08457 90 90 90.</li><li>SaneLine: telephone helpline: 0845 767 8000. Open from 6pm to 11pm every day of the year.</li></ul></li><li><strong>Provide written and verbal information about depression and its treatment. Good quality patient information can be found on the website of the Royal College of Psychiatrists (<a data-hyperlink-id="d2f20758-8c7e-4cd5-b84a-a98f015db561" href="http://www.rcpsych.ac.uk/">www.rcpsych.ac.uk</a>).</strong><ul><li>Leaflets include,<a data-hyperlink-id="93a0b09c-5777-4141-abf9-a98f015db62e" href="http://www.rcpsych.ac.uk/expertadvice/problemsdisorders/depression.aspx">Depression</a>,<a data-hyperlink-id="7b0db4bf-4512-4b06-b39d-a98f015db7db" href="http://www.rcpsych.ac.uk/expertadvice/problemsdisorders/depressionkeyfacts.aspx">Depression: key facts</a>,<a data-hyperlink-id="a53046f3-44b2-4a58-85a8-a98f015db974" href="http://www.rcpsych.ac.uk/expertadvice/problemsdisorders/depressioninolderadults.aspx">Depression in Older Adults</a>,<a data-hyperlink-id="870efb20-bc50-4a9f-8b4d-a98f015dbb06" href="http://www.rcpsych.ac.uk/expertadvice/problemsdisorders/depressionmenkeyfacts.aspx">Depression and Men: key facts</a>,<a data-hyperlink-id="ccc0fbc7-f60d-4968-9857-a98f015dbc97" href="http://www.rcpsych.ac.uk/expertadvice/treatmentswellbeing/antidepressants.aspx">Antidepressants</a>, and<a data-hyperlink-id="b2c90b34-fb5e-49fe-bf8b-a98f015dbcb5" href="http://www.rcpsych.ac.uk/expertadvice/treatmentswellbeing/cbt.aspx">Cognitive Behavioural Therapy</a>.</li></ul></li><li><strong>Advise the person receiving treatment:</strong><ul><li>To be vigilant for worsening depressive symptoms and suicidal ideas, particularly when starting and changing medications, and at times of increased personal stress. Advise them to seek help promptly if they are concerned.</li><li>That it usually takes 24weeks for symptoms to improve.</li><li>That antidepressants should be taken for at least 6months after they have recovered, to reduce the risk of relapse. People who are at high risk of relapse may need to take them for longer than this.</li><li>That antidepressant drugs are not addictive  however, inform them that discontinuation symptoms are experienced in a third of people who stop treatment.</li><li>That if they stop taking antidepressants abruptly, miss doses, or do not take the full dose, they may experience discontinuation symptoms. These can includerestlessness, problems sleeping, unsteadiness, sweating, abdominal symptoms, altered sensations (for example electric shock sensations in the head), or altered feelings (irritability, anxiety, confusion).<ul><li>Explain that whilst the withdrawal symptoms which arise when stopping or reducing antidepressants can be mild and self-limiting, there is substantial variation in people's experience, with symptoms lasting much longer (sometimes months or more) and being more severe for some patients.</li></ul></li><li>That some antidepressants potentially have sedating effects, and may affect the person's ability to drive. This effect is likely to be greatest in the first month after starting treatment or after increasing the dose. The Driver and Vehicle Licensing Agency (DVLA) advises that people should not drive during this time if affected.</li><li>Not to use St John's wort.</li></ul></li></ul><!-- end field 83efccd8-5aa3-4a80-ae9c-a70700ff5948 --><!-- end item 73afab8f-b298-425a-8bd1-a70700ff57bc --></div><section aria-labelledby="basis-for-recommendation-490" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-490">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 49049471-d436-4d29-978a-a70700ff594c --><!-- begin field f00509d6-d34b-4c7e-9c07-a70700ff594c --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidelines<em>Depression: the treatment and management of depression in adults</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>],theBritish Association for Psychopharmacology<em> Evidence-based guidelines for treating depressive disorders with antidepressants: arevision of the 2008 British Association for Psychopharmacology guidelines </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">Cleare, 2015</a>], and the Driver and Vehicle Licensing Agency (DVLA)guide<em>Assessing fitness to drive  a guide for medical professionals</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">DVLA, 2019</a>].</p><!-- end field f00509d6-d34b-4c7e-9c07-a70700ff594c --><!-- end item 49049471-d436-4d29-978a-a70700ff594c --></div></section></section><section aria-labelledby="follow-up" class="ChapterBody-module--wrapper--2HCfk "><h3 id="follow-up">When should I reviewsomeone with depression?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 007a0c6a-1a31-4b69-9a32-a70700ff20db --><!-- begin field a3a18443-9ce4-4a0c-bdc2-a70700ff22c1 --><ul><li><strong>The review period should be determined by the risk of suicide and the need to assess the tolerability and effectiveness of any treatments started or changed.</strong></li><li><strong>F</strong><strong><strong>or </strong>people not considered to be at an increased risk of suicide:</strong><ul><li>Arrange an initial review within 2 weeks.</li><li>Review regularly thereafter  for example,every 24weeks for the first 3months and if the response to treatment is good, longer review intervals can be considered.</li></ul></li><li><strong>For people at an increased risk of suicide, or people aged under 30 years:</strong><ul><li>Arrange an initial review within 1 week.</li><li>Review frequently thereafter until the risk is no longer considered clinically important.</li></ul></li></ul><!-- end field a3a18443-9ce4-4a0c-bdc2-a70700ff22c1 --><!-- end item 007a0c6a-1a31-4b69-9a32-a70700ff20db --></div><section aria-labelledby="basis-for-recommendation-c8e" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-c8e">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item c8ee52fb-239a-45f4-a905-a70700ff22c5 --><!-- begin field 6209faa0-c433-4b02-b978-a70700ff22c5 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) guidelines<em>Depression: the treatment and management of depression in adults</em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">National Collaborating Centre for Mental Health, 2019</a>].</p><!-- end field 6209faa0-c433-4b02-b978-a70700ff22c5 --><!-- end item c8ee52fb-239a-45f4-a905-a70700ff22c5 --></div></section></section></section></div></div></div><div class="BackToTop-module--wrapper--2Z0EU"><nav aria-labelledby="back-to-top-link" class="BackToTop-module--nav--1DPZ6"><a class="BackToTop-module--anchor--1Nia6" id="back-to-top-link" href="index.html#content-start"><div class="container"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="icon" aria-hidden="true" focusable="false"><path d="M478.152 338.576c0 10.091-3.525 18.661-10.576 25.712l-21.424 21.424c-7.243 7.243-15.909 10.864-26 10.864-10.283 0-18.853-3.621-25.712-10.864L255.576 247.136 116.712 385.712c-6.859 7.243-15.429 10.864-25.712 10.864s-18.853-3.621-25.712-10.864l-21.424-21.424C36.621 357.429 33 348.859 33 338.576c0-10.091 3.621-18.757 10.864-26l186-186c7.051-7.051 15.621-10.576 25.712-10.576 9.909 0 18.576 3.525 26 10.576l185.712 186c7.243 7.243 10.864 15.909 10.864 26z" fill="currentColor"></path></svg> Back to top</div></a></nav></div></main><footer class="Footer-module--footer--2QrGZ"><div class="Footer-module--container--1iuoB"><a href="https://www.nice.org.uk/" class="Footer-module--logo--3DGKv" aria-label="Go to NICE home page"></a><nav class="Services-module--wrapper--2qOoE" aria-label="Our services"><ul class="Services-module--list--3SZQu"><li><a href="https://pathways.nice.org.uk/" class="Services-module--link--2y_1q">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Services-module--link--2y_1q">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Services-module--link--2y_1q">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Services-module--link--2y_1q">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary">BNF<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Services-module--link--2y_1q"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Services-module--visuallyHidden--t9mfm">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">Clinical Knowledge Summaries</span></a></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Services-module--link--2y_1q">Journals and databases</a></li></ul></nav><nav class="Pages-module--wrapper--30REl"><ul class="Pages-module--list--vvSk4"><li><a href="https://www.nice.org.uk/about">About NICE</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/into-practice">Into practice</a></li><li><a href="https://www.nice.org.uk/get-involved">Get involved with NICE</a></li><li><a href="https://www.nice.org.uk/get-involved/jobs">Jobs</a></li><li><a href="https://www.nice.org.uk/news">News</a></li><li><a href="https://www.nice.org.uk/news/nice-newsletters-and-alerts">Newsletters and alerts</a></li><li><a href="https://www.nice.org.uk/get-involved/contact-us">Contact us</a></li><li><a href="https://www.nice.org.uk/leave-feedback">Leave feedback</a></li><li><a href="https://www.nice.org.uk/re-using-our-content">Reusing our content</a></li><li><a href="https://www.nice.org.uk/re-using-our-content/uk-open-content-licence">NICE UK Open Content Licence</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/nice-syndication-api">Syndicate our content</a></li></ul></nav><div class="Social-module--wrapper--2nKsd"><ul class="Social-module--list--E5R5J" aria-label="NICE on social media"><li><a href="https://en-gb.facebook.com/NationalInstituteforHealthandCareExcellence/">Facebook</a></li><li><a href="https://twitter.com/NICEcomms">Twitter</a></li><li><a href="https://www.youtube.com/user/NICEmedia">YouTube</a></li><li><a href="https://www.instagram.com/nicecomms/">Instagram</a></li><li><a href="https://www.linkedin.com/company/national-institute-for-health-and-clinical-excellence">LinkedIn</a></li></ul></div></div><div class="Legal-module--wrapper--3AYMO"><div class="Legal-module--container--3TTBh"><nav class="Legal-module--menu--1e1Iy" aria-label="Legal menu"><ul><li><a href="https://www.nice.org.uk/accessibility">Accessibility</a></li><li><a href="https://www.nice.org.uk/freedom-of-information">Freedom of information</a></li><li><a href="https://www.nice.org.uk/glossary">Glossary</a></li><li><a href="https://www.nice.org.uk/terms-and-conditions">Terms and conditions</a></li><li><a href="https://www.nice.org.uk/privacy-notice">Privacy notice</a></li><li><a href="https://www.nice.org.uk/cookies">Cookies</a></li></ul></nav><p class="Legal-module--copyright--34nsI"><!-- --> <abbr title="National Institute for Health and Care Excellence">NICE</abbr> <!-- -->2021<!-- -->. All rights reserved. Subject to<!-- --> <a href="https://www.nice.org.uk/terms-and-conditions#notice-of-rights">Notice of rights</a>.</p></div></div></footer></div><div id="gatsby-announcer" style="position:absolute;top:0;width:1px;height:1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);white-space:nowrap;border:0" aria-live="assertive" aria-atomic="true"></div></div><script id="gatsby-script-loader">/*<![CDATA[*/window.pagePath="/topics/depression/management/new-or-initial-management/";/*]]>*/</script><script id="gatsby-chunk-mapping">/*<![CDATA[*/window.___chunkMapping={"polyfill":["/polyfill-2cb897c2a056d28c9332.js"],"app":["/app-53a71c38b210970893c4.js"],"component---cache-caches-gatsby-plugin-offline-app-shell-js":["/component---cache-caches-gatsby-plugin-offline-app-shell-js-258fa972005c75a2a109.js"],"component---src-pages-404-tsx":["/component---src-pages-404-tsx.4b20f8dadfa146d0f95d.css","/component---src-pages-404-tsx-db046304e34e9a4e982b.js"],"component---src-pages-about-development-tsx":["/component---src-pages-about-development-tsx.4c5b5dd941fb0f6fd929.css","/component---src-pages-about-development-tsx-a805dcaba6372bd3fd34.js"],"component---src-pages-about-index-tsx":["/component---src-pages-about-index-tsx.a9a4b7f951b698486005.css","/component---src-pages-about-index-tsx-d5e998d3f688352286e1.js"],"component---src-pages-index-tsx":["/component---src-pages-index-tsx.49dafffcf9ae0c5f0d9f.css","/component---src-pages-index-tsx-6cc2ff789de11ec327f6.js"],"component---src-pages-search-tsx":["/component---src-pages-search-tsx.f915457cd8b05c27e895.css","/component---src-pages-search-tsx-a51f99760cb0d47808e2.js"],"component---src-pages-specialities-tsx":["/component---src-pages-specialities-tsx.fc62cf637c7ba1e609e7.css","/component---src-pages-specialities-tsx-90b8d3e5a5a3bff52a17.js"],"component---src-pages-topics-tsx":["/component---src-pages-topics-tsx.dfa0c1027e3cbeb11bdc.css","/component---src-pages-topics-tsx-960f75c13acbee11c017.js"],"component---src-pages-whats-new-tsx":["/component---src-pages-whats-new-tsx.7f7660f22ce5e07ac85a.css","/component---src-pages-whats-new-tsx-f78b713a66b42005fd9f.js"],"component---src-templates-chapter-level-1-chapter-level-1-tsx":["/component---src-templates-chapter-level-1-chapter-level-1-tsx.1a16ce552cccd7e50c41.css","/component---src-templates-chapter-level-1-chapter-level-1-tsx-0a03778bb80ba711929e.js"],"component---src-templates-chapter-level-2-chapter-level-2-tsx":["/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css","/component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"],"component---src-templates-speciality-speciality-tsx":["/component---src-templates-speciality-speciality-tsx.fc62cf637c7ba1e609e7.css","/component---src-templates-speciality-speciality-tsx-3357943d471e489a1b5f.js"],"component---src-templates-topic-topic-tsx":["/component---src-templates-topic-topic-tsx.afc04214919e241c3c2e.css","/component---src-templates-topic-topic-tsx-f17fe03d0b9a54a96aea.js"]};/*]]>*/</script><script src="../../../../polyfill-2cb897c2a056d28c9332.js" nomodule=""></script><script src="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js" async=""></script><script src="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js" async=""></script><script src="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js" async=""></script><script src="../../../../app-53a71c38b210970893c4.js" async=""></script><script src="../../../../framework-34da02e39e1f104d9937.js" async=""></script><script src="../../../../webpack-runtime-28c424ef71f39faedaf0.js" async=""></script></body></html>